Method of performing a process for determining an item of interest in a sample

Description

BACKGROUND
Embodiments described herein relate generally to methods and structures which determine an item of interest in a sample.
To provide information about a patient's health, a number of tests can be performed on a patient sample, such as the patient's bodily fluids. These bodily fluids may include blood, urine, etc. The tests performed on the patient's bodily fluids can determine an item of interest in the bodily fluids. Based on the determination of the item of interest in the patient's bodily fluids, information about the patient's health status can be obtained.
SUMMARY
Embodiments described herein provide methods of performing a process for determining an item of interest in a sample. In one embodiment, a container for holding the sample is accepted in a process lane where a process step is selectively automatically performed on the sample in the container. The process step is selectively automatically performed on the sample in the container. An effective length of the process lane is maintained constant while a physical length of the process lane is selectively varied.
In another embodiment, a container for holding the sample is accepted in a process lane where a process step is selectively automatically performed on the sample in the container. The process step is selectively automatically performed on the sample in the container. A physical length of the process lane is selectively varied.

BRIEF DESCRIPTION OF DRAWINGS
FIG. 1 is a perspective view of a component of an analyzer;
FIG. 2 shows the component of FIG. 1 with elements thereof removed for clarity;
FIG. 3 is a perspective view of an element of the component shown in FIG. 1;
FIG. 4 is a top view of the component of FIG. 1 with elements thereof removed for clarity;
FIGS. 5A and 5B show another element of the component of FIG. 1 which is connected with the structure shown in FIG. 2;
FIG. 6 is an enlarged sectional view of the component of FIG. 1 with elements removed for clarity;
FIG. 7A is a perspective view of a container for use with the component of FIG. 1;
FIG. 7B is a perspective view of another container for use with the component of FIG. 1;
FIG. 8 is an enlarged sectional view of a portion of the component of FIG. 1 showing interaction with the container of FIG. 7B;
FIG. 9 is an enlarged sectional view, substantially similar to that of FIG. 8, of another portion of the component of FIG. 1;
FIG. 10 is substantially similar to FIG. 9 but shows another portion of the component of FIG. 1;
FIG. 11 is substantially similar to FIG. 10 but shows another portion of the component of FIG. 1;
FIG. 12 is a perspective view of an element of the component of FIG. 1;
FIG. 13 is an enlarged sectional view of a section of another embodiment of the component shown in FIG. 1;
FIG. 14 is a perspective view of an element of the component of FIG. 1;
FIG. 15 is a perspective view of an element of the component of FIG. 1;
FIG. 16 is a generic view of the component of FIG. 1 cooperating with other portions of an analyzer;
FIG. 17 is a perspective view of a frame for the structures shown in FIG. 16;
FIGS. 18A, 18B and 18C illustrate an element of the component shown in FIG. 1;
FIG. 19 is an enlarged sectional view of a section of another embodiment substantially similar to that shown in FIG. 13;
FIGS. 20A and 20B are generic views of other related analyzers having oppositely directed components substantially similar to the component of FIG. 1;
FIGS. 21A, 21B and 21C show an embodiment of a high density data carrier which may be used with the component of FIG. 1;
FIG. 22 is an isometric view of a container for use with the process path of FIG. 1;
FIGS. 23A, 23B and 23C show another container for use with the process path of FIG. 1;
FIGS. 24A and 24B are enlarged sectional views of a portion of the container of FIGS. 23A, 23B and 23C operatively associated with a support;
FIG. 25 is an isometric view of a seal which may be used with the containers of FIGS. 22, 23A, 23B and 23C;
FIG. 26 is an enlarged section of another application of the process path of FIG. 1;
FIG. 27 is an enlargement of a portion of FIG. 27;
FIG. 28 is a generic view of another related analyzer having a component substantially similar to the component of FIG. 1;
FIG. 29 is an illustration of two components of FIG. 1 joined together;
FIG. 30 is an enlarged view of a portion of FIG. 29;
FIGS. 31A, 31B and 31C show another container for use with the process path of FIG. 1; and
FIGS. 32A and 32B illustrate portions of another embodiment of the process path.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
The embodiments described herein relate to methods and structures for determining an item of interest in a sample. The item of interest may be an antibody, an antigen, concentrations of the former or latter or any other desired element of the sample. In an exemplary embodiment, the item of interest is selected from, but are not limited to, antibodies to HCV, antibodies to HIV 1/HIV 2, antibodies to hepatitis B core antigen (HBcAb), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), Hepatitis B Surface Antigen (HBsAg), antibodies to Hepatitis B Surface antigen (HBsAb), alpha-fetoprotein (AFP), Total prostate specific antigen (Total PSA) Free PSA, Thyroid stimulating Hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), beta human chorionic gonadotropin (B-hCG), Free Thyroxine (Free T4), Free triiodothyronine (Free T3), Total T4, Total T3, Progesterone, Testosterone, Estradiol, Prolactin, vitamin B12 (B12), Folate, Glycated Hemoglobin, and Ferritin. The structures and methods may be employed in a number of different configurations.
For the sake of clarity of understanding, the structures and methods will be discussed with respect to their employment in an immunoassay analyzer which performs approximately 200 determinations of items of interest in a sample in an hour. It is to be noted that the structures and methods can be used in other employments, such as analyzers which perform 600, 400, 100, 50, etc. determinations in an hour. A number of analyzers may be joined together or integrated to meet individual needs, such as modifying the number of tests performed in a given time period (throughput), tailoring the items of interest to be determined, etc. For example a number X of analyzers which perform Y determinations in a given hour may be connected such that the connected analyzers perform XY determinations in an hour.
It is to be noted that all such analyzers perform all determinations of items on interest in substantially the same way. For instance, all determination process steps for all items of interest are performed within the same time frame, such as 18 seconds, irrespective of the number or type of determinations to be performed by the given analyzer. These analyzers may include common elements, such as reagents, disposable articles, element, such as fluids and the like, delivery technologies, determination step performance mechanisms, software, etc.
In other applications, the analyzer may be joined, e.g. with a conveyor system and the like, along with supporting hardware and software, such that the analyzer can be used with different analyzers, such as clinical chemistry or hematology analyzers and the like, in the same setting. This conveyor system may move samples among the analyzers such that different determinations can be made with respect to one sample. Also, while operation of the analyzer is described herein with respect to only one analyzer, for the sake of clarity, it is to be remembered that multiple analyzers can operate in the same of in different fashion, either simultaneously or at different times. Furthermore, steps of one method of operation can be combined with steps of another method of operation to arrive at yet more methods of operation.
As illustrated in FIG. 1, the analyzer comprises a process path 10. It is understood that there are other elements (not shown), such as fluid delivery mechanisms, suppliers, and the like, of the analyzer that support operation of the process path 10. While the process path 10 is illustrated as being substantially circular in configuration, the process path 10 may take other configurations, such as linear, serpentine, etc., as desired.
The process path 10 includes a cover 12 and a base 14. The base 14 may be attached to a support frame (FIG. 17) and the cover 12 is attached to the base 14. The cover 12 may be a single piece or may comprise multiple, sometimes 6, pieces. Various elements, some of which are described below, of the process path 10 are connected to at least one of the cover 12 and the base 14. The cover 12 and the base 14 include structures, such as openings and the like, for accommodating some of the elements. In one embodiment, the base 14 has an inner diameter of about 24.58 inches, an outer diameter of about 30.08 inches and a height of about 1.99 inches. The base 14 may be made of any suitable material, such as a metal, a polymer and the like. In one embodiment, the base 14 is made of anodized aluminum, including a reduced friction coating, such as a PTFE-impregnated anodized coating. In a particular embodiment, the base 14 is made from 6061-T6 aluminum with a MIL-A-63576, Type I finish. The cover 12 may be made of a material which is substantially similar to the material of the base 14.
FIG. 2 shows the process path 10 with the cover 12 removed from the base 14. With the cover 12 removed, a disk 16 is visible. The disk 16 is located between the cover 12 and the base 14 and is movable with respect to both the cover 12 and the base 14.
In some embodiments, the disk 16 may be replaced by a belt 16*, shown in FIGS. 32A and 32B, driven by a wheel 17. Use of the belt 16* provides for orientations other than substantially circular, i.e. serpentine and like, of the process path 10. The belt 16* moves with respect to the cover 12 and the base 14 in substantially the same manner as the disk 16. In other aspects, construction of the process path 10 is substantially similar irrespective of use of the disk 16 or the belt 16*.
The disk 16, illustrated more clearly in FIG. 3, has, in one embodiment, an inner radius of about 25.2 inches and an outer radius of about 29.3 inches. The disk 16 may have a thickness of about 0.063 inches. The disk 16 may be formed from any suitable material, such as a polymer and the like. In a particular embodiment, the disk 16 is made from polyvinyl chloride. The disk 16 may be machined, molded or the like. In an exemplary embodiment, the material comprising the disk 16 is chosen with respect to the material of the base 14 to reduce friction between the base 14 and the disk 16.
A plurality 112 in the illustrated embodiment, of slots 18 are disposed on the disk 16. As is discussed in greater detail later, the slots 18 cooperate with structures on the base 14 to move containers 15 (FIGS. 7A and 7B) along the process path 10. Each slot 18 has, with respect to the disk 16 in an exemplary embodiment, a radial length of about 1.75 inches and a tangential width of about 0.45 inches with a slot 18 centerline being located at a radius of about 13.614 inches. As is discussed further below, the slot 18 has a longitudinal axis and the container 15 is capable of moving within the slot 18 along the slot's 18 longitudinal axis. To facilitate movement of the container 15 along the longitudinal axis of the slot 18, the process path 10 may include a configuration, such as a surface, a diverter, a prime mover engagable with the container 15, and the like. In another embodiment, one end of the slot 18 may include a latitudinally expanded width (FIG. 13) to facilitate removal of a container 15 from the disk 16. In still a further embodiment, the latitudinally expanded width may be located at another region of the slot 18 (FIG. 19).
The disk 16 is configured to facilitate movement of the disk 16 with respect to the cover 12 and the base 14. In one embodiment, a plurality of teeth 20 are disposed along an outer diameter surface of the disk 16. In an exemplary embodiment, the teeth 20 may be about 938 in number with a diametral pitch of about 32, a pressure angle of about 20 degrees and a pitch diameter of about 29.3125 inches.
As shown in FIG. 6, the teeth 20 mate with a gear 22 which is driven by a prime mover 24 attached to the cover 12 by a bracket 26. In an exemplary embodiment, the gear 22 is made from Estane 58130 natural 92A/50D polyurethane and the motor 24 is a P21 model available from Pacific Scientific of Rockford, Ill. The prime mover 24, the entire process path 10 and its supporting elements, are connected with and are operated by a suitable controller, such as a computer (not shown) running appropriate routine and the like. In this manner, the disk 16 moves responsive to movement of the gear 22 by the prime mover 24. In a particular embodiment, the prime mover 24 is a stepper motor.
Referring to FIG. 4, the base 14 includes structures to facilitate determination of an item of interest in a sample. The base 14 comprises at least one lane 28 for guiding movement of a container 15 along the process path 10 responsive to movement of the disk 16. As the disk 16 moves responsive to activation of the prime mover 24, the container 15 moves along the lane 28 from one processing station to another to complete determination of the item of interest in the sample.
In the illustrated embodiment, there are a first processing lane 28 and a loading lane 30 in the process path 10. Complimentary portions of the lanes 28 and 30 are formed in both the cover 12 and the base 14. Because these two lanes 28 and 30 are substantially concentric, the disk 16, which is adjacent to both lanes 28 and 30, and its slots 18 are dimensioned to accept and to support containers 15 disposed in both the process lane 28 and the loading lane 30 at substantially the same circumferential position, while being radially offset, on the disk 16. In an exemplary embodiment, the lanes 28 and 30 have a width of about 0.279 inches at the top and have a draft angle of about 1.5 degrees.
As shown in FIGS. 18A, 18B and 18C, in one embodiment, the loading lane 30 accepts and orients containers 15 from a container 15 supply or hopper 102. A disk 104 including a projection 106 is moved within the hopper 102 by a prime mover 108. In some embodiments, structures may be included with the hopper 102, such as a baffle for directing container 15 movement within the hopper 102 responsive to disk 104 movement, an "inherent flat spring" actuated by a cam driven mechanism associated with the disk 104 to move containers 15 within the hopper 102, and the like, to facilitate movement of the containers 15. As the disk 104 moves within the hopper 102, the projection 106 is inserted through the top surface 42 of a container 15 in the hopper 102. The projection 106 carries the container 15 toward a loading mechanism 110, which may include a mover 111, such as a barrel cam and the like, for moving a container 15 from the hopper 102 toward the loading lane 30. As the container 15 approaches the loading lane 30, in one embodiment, another mover 112, such as a solenoid-driven rod and the like, moves the container 15 into a slot 18 in the disk 16 at the loading lane 30. Alternatively, the container 15 may move from an end of the mover 111 into a slot 18 in the disk 16 at the loading lane 30 under the influence of gravity.
In an exemplary embodiment, the hopper 102 is made from Lexan WR2210 (GE Plastics of Pittsfield, Mass.) with a black SPI B1 finish and has a volume substantially within the range of about 396 to about 540 cubic inches, thereby allowing the hopper 102 to hold approximately 1000 containers 15. The disk 104 is made from Lexan 500 with a finish of gray SPI B1 and the projection 106 is made from Lexan WR2210 with a finish of black SPI B1. The disk 104 includes four projection 106 mounts spaced equidistantly along a circumference of the disk 104, i.e. every 90 degrees, at a radius of about 4.5 inches from a center of the disk 102. To assist movement of containers 15 within the hopper 102, the disk 102 includes a plurality, such as four, of nubs having a spherical radius of about 0.165 inches spaced equidistantly along a circumference of the disk 104, i.e. every 90 degrees, at a radius of about 3.312 inches from a center of the disk 102. The projection 106 has a nominal thickness of about 0.1 inches and a length of about 0.9 inches. The projection 106 is aligned substantially tangentially to a 4.5 inch radius of the disk 102. The mover 108 may be No. 78431-101 from Pacific Scientific of Elgin, Ill. The mover 111 includes a screw made from Delrin 500 having a black SPI B1 finish. The screw is about 7.126 inches long and has 18 threads of a diameter measuring about 0.706 inches and of a pitch of about 0.394 inches. The screw is connected to a drive gear made from Celcon M90 having a finish of black SPI B1. The drive gear is an involute gear having 24 teeth with a diametral pitch of about 32, a pressure angle of about 20 degrees and a pitch diameter of about 0.75 inches. The mover 112 may be No. 78851-102 available from Haydon Switch & Instrument of Waterbury, Conn. In other embodiments, No. 78425-101 available from SPM/Portland of Hillsboro, Oreg. may be used for some of the components.
As shown in FIGS. 7A and 7B, the container 15 includes a sample receiving chamber 32 and a pair of support surfaces 34A and 34B connected with the sample receiving chamber 32. As shown in FIG. 8, the support surfaces 34A and 34B rest on portions of the disk 16 which bound the slot 18. The chamber 32 is formed by two sets of side walls 36A, 36B, 38A and 38B and a bottom wall 40. In an exemplary embodiment, the largest external distance between the side walls 36A and 36B, which have a rib width of about 0.020 inches, is about 0.26 inches, the largest external distance between the side walls 38A and 38B is about 0.44 inches, the support surfaces 34A and 34B extend a distance measuring about 0.085 inches from the side walls 38A and 38B, respectively, the maximum length of the container 15 is about 1.445 inches, an open end of the sample receiving chamber 32 measures about 0.391 inches by about 0.219 inches, a nominal thickness of the walls 36A, 36B, 38A and 38B is about 0.030 inches, an inside depth of the sample receiving chamber 32 is about 1.34 inches having a volume of about 1.4 ml and a volume of the sample receiving chamber 32 at a location, from which determination measurements are made, measuring about 0.699 inches from a bottom of the container 15 is about 0.45 ml. A top surface 42 of the container 15 is located a distance measuring about 0.18 inches from the support surfaces 34A and 34B. The container 15 may be made from Escorene 3345-E5 (Exxon, Houston, Tex.) or Montell PD701N (Wilmington, Del.) with an internal finish of polished SPE/SPE 1 B-2.
Returning to FIGS. 4 and 8, cooperation among the container 15, the slots 18 in the disk 16 and the lanes 28 and 30 facilitate movement of the container 15 along the process path 10. Specifically, the dimensions of the container 15, the slots 18 and the lanes 28 and 30 are predetermined such that the support surfaces 34A and 34B of the container 15 radially slidingly engage the disk 16 adjacent to the slot 18 in which the container 15 is disposed while the container 15 itself is restrained from rotation within the slot 18. In one embodiment, the process lane 28 has a radius of about 27.6 inches and a width of about 0.28 inches while the loading lane 30 has a smaller radius but a similar width. The container 15 is disposed such that axes of the side walls 36A and 36B are positioned substantially radially with respect to the process path 10 and the support surfaces 34A and 34B are aligned substantially circumferentially with respect to the process path 10. In this manner, as the disk 16 moves responsive to activation of the prime mover 24, the container 15 within the slot 18 moves substantially tangentially to the process path 10 within the lanes 28 and 30.
As the process path 10 may be used with biological samples, it is desirable to maintain the process path 10, or portions thereof, at a suitable temperature, such as 37 degrees Celsius, to facilitate determination of the item of interest. Thus, a heater (not shown), such as an electric heater and the like, may be thermally associated with the process path 10. In an exemplary embodiment, a plurality of electric resistive flexible strip heaters may be applied, such as by a suitable adhesive and the like, to the cover 12 and/or the base 14 of the process path 10. These heaters apply sufficient thermal energy to the process path 10 such that the contents of the container 15 is maintained at the desired temperature. Also, because the loading lane 30 is part of the process path 10, it is possible to bring the container 15 to the desired temperature prior to addition of anything to the container 15. For example, if determination of an item of interest in a sample is performed optimally at a given temperature; the container 15 in the loading lane 30 can be brought to that given temperature at a certain time period after introduction of the container 15 from the hopper to the loading lane 30 but before the container 15 is needed to perform the desired determination. Suitable temperature control devices, such as thermistors and the like, are also provided along the process path 10. Additionally, in some embodiments, materials, such as reagents and the like, to be added to the container 15 may be heated prior to addition to the container 15. In some cases, the material delivery apparatus, such as a fluid conduit and the like, may be associated with appropriate heaters and heat sensors.
When a container 15 is needed to perform a given item of interest determination, the container 15 is moved from the loading lane 30 to the process lane 28. This function is performed at location 48 shown at FIG. 4. To move the container 15 from the loading lane 30 toward the process lane 28, as shown in FIG. 10, a prime mover 44, mounted on the process path 10, is operated. A container 15 engaging member 46 operatively connected with the prime mover 44 bears against the side wall 36A of the container 15 and moves the container 15 radially outward with respect to the disk 16 within the slot 18 from the loading lane 30 towards the process lane 28 responsive to activation of the prime mover 44. In an exemplary embodiment, the member 46 is made from 6061-T6 aluminum with a MIL-A-63576, Type I finish. The member 46 may include structures, such as a slot, which mate with complimentary structures, such as a pin, on the prime mover 44 to provide desired alignment of the mover 44 and the arm 46 and to limit undesired movement, such as rotation, of the member 46. Operation of the prime mover 44 causes the member 46 to move a distance of about 0.5 inches with a minimum starting force of about 7.08/.25 gm/oz and a minimum ending force of about 56.7/2.0 gm/oz.
To accommodate movement of the container 15, a passageway 50 is formed on the cover 12 and the base 14 connecting the process lane 28 with the loading lane 30. Once the container 15 is in the process lane 28, the prime mover 44 moves the container 15 engaging member 46 away from the container 15 just moved to a waiting position to move another container 15 from the loading lane 30 toward the process lane 28. In an exemplary embodiment, the prime mover 44 is a solenoid, a pneumatically actuated motor, a linear positioner or the like. In a particular embodiment, the prime mover 44 is an electric solenoid with its windings modified such that the solenoid travel occurs without splashing or spilling of container 15 contents.
Now that the container 15 has been moved from the loading lane 30 to the process lane 28, movement of the disk 16 causes the container 15 to move along the process lane 28 for performance of determination of an item of interest in a sample. In some cases, the sample, such as blood or other bodily fluids, added to the container 15 is in liquid form. Also, in some cases, other substances, such as reagents and the like, are added to the sample in the container 15 during determination of an item of interest in the sample. These other substances may also be in liquid form.
As these liquids are added to the container 15 it is possible that some of the liquids may not end up within the container 15 but may be disposed on the disk 16 or other portions of the process path 10. To substantially remove these liquids, drain ducts 52 are provided on the base 14 of the process path 10. These drain ducts 52 are recessed from a groove 54 on the base 14 in which the disk 16 is disposed. In an exemplary embodiment, the drain ducts 52, about 112 in number, are equidistantly spaced along a circumference of the base 14, recess a distance of about 0.125 inches from the groove 54, have an internal angle of about 90 degrees and are about 0.05 inches deep and about 0.1875 inches wide. In some embodiments, the drain ducts 52 may be inclined toward the process lane 28 such that liquid within the drain ducts 52 will move under the influence of gravity toward and into the process lane 28. In the illustrated embodiment, the drain ducts 52 are oriented in an expected direction of disk 16 rotation. In this embodiment, liquid movement within the drain ducts 52 is encouraged by movement of the disk 16. Similar drain ducts 52 may be formed on the cover 12. To facilitate substantial removal of the liquids from the process lane 28, drain holes 56 are provided in the base 14 at various locations along bottom portions of the process lane 28.
The process of determining an item of interest in a sample comprises a number of steps. However, given the specific item of interest to be determined, different steps are to be performed. For instance, for determination of a first item of interest, three process steps are to be performed, whereas for a second item of interest, only two process steps are to be performed. These process steps may include, for example, solid/liquid phase (for example, magnetic) separation, aspiration of container 15 contents, container 15 contents washing, etc. To offer determination of both the first and second items of interest, the process path 10 includes structures for selective automated performance of process steps. However, it is to be noted that the process path 10 includes all structures necessary to perform all process steps for determining a predetermined set of items of interest.
At at least one location along the process lane 28, structures or elements for providing selective automated performance of a determination of item of interest process step are disposed. As shown in FIG. 4, in one embodiment, these structures or elements are located in a bypass region of the process path 10. In the illustrated embodiment, the process path 10 includes three bypass regions 58A, 58B and 58C. At the bypass regions 58A, 58B and 58C, the process lane 28 is radially expanded with respect to other portions of the process lane 28. In an exemplary embodiment, the process lane 28 at the bypass regions 58A, 58B and 58C is about 0.65 inches wide radially. The radial expansion of the process lane 28 at the bypass regions 58A, 58B and 58C allows the container 15 to be positioned at multiple places longitudinally along the slot 18 and radially with respect to the disk 16 at the bypass regions 58A, 58B and 58C. Depending on the position of the container 15 within the slot 18 in the disk 16, the container 15 may or may not participate in the item of interest determination process step performed at the bypass regions 58A, 58B and 58C.
In an alternate embodiment, the structures or elements for providing selective automated performance of a determination of item of interest process step may include routines, such as those embodied in software, hardware and the like, for selectively activating or deactivating certain process path 10 elements, such as a wash zone and the like, selectively moving process path 10 elements into and out of a process step performance position with respect to the process path 10, such as moving a magnet and the like, or any appropriate combination of the methods discussed herein.
The cover 12 also includes structures forming the bypass regions 58A, 58B and 58C on the process path 10. As shown in FIGS. 5A and 5B, a wall 60 on the cover 12 separates the process lane 28 on the cover 12 at the bypass regions 58A, 58 and 58C into a process step performance lane 62 and a process step avoidance lane 64 offset radially on the cover 12. The wall 60 engages a portion of the side walls 36A and 36B adjacent of top surface 42 of the container 15 to guide the container 15 through either the process step performance lane 62 or the process path avoidance lane 64.
To encourage a desired container 15 into the desired one of the process step performance lane 62 or the process step avoidance lane 64, a prime mover 44 connected with a container engaging member 46 is provided attached to the process path 10, as shown in FIG. 9. The structure illustrated in FIG. 9 is substantially similar to the construction illustrated in FIG. 10, hence the like reference numbers. Activation of the prime mover 44 enables selective radial positioning of the container 15 at either an inner 66 or outer radial edge 68 (FIGS. 5A and 5B) of the process lane 28. Once so positioned, advancement of the disk 16 with respect to the base 14 moves the container 15 into the preselected one of the process step performance lane 62 or the process step avoidance lane 64.
In some embodiments, the prime mover 44, and/or the wall 60 may be constructed to take advantage of natural movement of the container 15 in the process lane 16. For instance, the container 15 may tend to move radially outwardly along the process lane 28. In this case, the prime mover 44 and/or the wall 60 may be constructed such that a container 15 moved toward the process step avoidance lane 64 moves toward that lane 64 under centrifugal force without any assistance from the prime mover 44. In this case, the prime mover 44 would only act on a container 15 to be moved into the process step performance lane 62.
In the illustrated embodiment, the bypass regions 58A, 58B and 58C are positioned along the process lane 28 dependent upon the anticipated frequency of performance and avoidance of a particular process step. This frequency is, in turn, dependent upon a particular step of determinations of items of interest to be performed with the process path 10. Also, depending upon the determinations to be performed, there may be more or less bypass regions 58A, 58B and 58C provided.
Illustrating further by example, the process lane 28 diverges radially prior to entering the bypass region 58A (FIGS. 5A and 5B). The process lane 28 enters the bypass region 58A along its outer radial edge. Since performance of the process step occurs at the inboard process step performance lane 62 of the bypass region 58A, the prime mover 44 associated with the bypass region 58A moves the container 15 radially inward toward the process step performance lane 62 only if performance of this process step were desired. If performance of this process step were not desired, then the prime mover 44 would not be activated and the container 15 would remain on the outer radius surface of the process lane 28 and move into the process step avoidance lane 64 upon movement of the disk 16. This construction favors performance of a set of determinations where performance of the relevant process step is required for a minority of the determinations to be performed.
If the set of determinations were to change such that performance of the relevant process step is required for a majority of the determinations to be performed, then it may be desirable to construct the bypass region 58A substantially similarly to the bypass regions 58B and 58C. At the bypass regions 58B and 58C, the process lane 28 enters the bypass regions 58B and 58C at its inner radial edge. Thus, if the prime mover 44 is not activated, then the container 15 would move under the influence of movement of the disk 16 into the process step performance lane 62 and the process step would be performed. The prime mover 44 would be activated only to move those containers 15 that did not require performance of this process step. Of course, this would represent a minority of the determinations to be performed with the process path 10.
Once a container 15 is in one of the bypass regions 58A, 58B or 58C, movement of the container 15 through the bypass region 58A, 58B or 58C is controlled by cooperation among the disk 16, edges of the process step performance and avoidance lanes 62 and 64 and the wall 60. The container 15 moves substantially tangentially through the process path 10 under the influence of rotation of the disk 16. The position of the container 15 radially within the radially inner-most one of the process step performance lane 62 (e.g. bypass region 58A) or the process step avoidance lane 64 (e.g. bypass region 58B) is maintained by an inner radial edge of the wall 60. A radius defining this inner radial edge of the wall 60 gradually increases along the wall 60 from a first end 70 to a second end 72 thereof. The container 15 is moved radially outward as the container 15 moves through the bypass region 58A, 58B or 58C. A radius defining an inner edge of the process step performance lane 62 (e.g. bypass region 58A) and the process step avoidance lane 64 (e.g. bypass region 58B) also increases from one end of the bypass region 58A, 58B or 58C adjacent the first end 70 of the wall 60 to an opposite end of the bypass region 58A, 58B or 58C adjacent the second end 72 of the wall 60. Thus, a portion of the container 15 adjacent its top surface 42 is maintained adjacent the wall 60, thereby maintaining intended positioning of the container 15 within the bypass regions 58A, 58B and 58C.
Once the determination of an item of interest is complete, the relevant container 15 is removed from the process lane 28 and the process path 10 altogether. AS shown in FIG. 11, a prime mover 74 is connected with the process path 10. The prime mover 74 drives a container 15 engaging surface 76 which acts on the container 15 adjacent the top surface 42 of the container 15. The prime mover 74, which may be a stepper motor and the like, drives the container engaging surface 76 to rotate the container 15 about 90 degrees with respect to the disk 16. This occurs at location 78 shown in FIG. 4. The process path 10 at the location 78 is configured to allow axial rotation of the container 15 and includes an aperture 80 having dimensions larger than corresponding dimensions of the container 15.
In an exemplary embodiment, the prime mover 74 may be a solenoid such as P/N 197855-001 BTA 2 DV 90.degree. available from Lucas Control Systems Products of Vandalia, Ohio. The surface 76 may be made from 6061-T6 aluminum with a MIL-A-63576, Type I finish and moves approximately 90 degrees responsive to operation of the prime mover 74.
Once the container 15 has been rotated, the support surfaces 34A and 34B of the container 15 are no longer in engagement with the disk 16. Under the influence of gravity, the container 15 falls through the aperture 80 in the process path 10 into a waste receptacle (not shown). In some constructions, a chute may be provided to guide the container 15 from the process path 10 toward the waste container. In other constructions, liquid present in the container 15 may be removed from the container 15 prior to encountering the prime mover 74.
With the container 15 being removed from the process lane 28, another container 15 within the same slot 18 on the disk 16 can be moved from the loading lane 30 to the process lane 28 as soon as the relevant slot 18 reaches the location 48. In some instances, it may not be desirable to remove a container 15 from the process lane 28 once that container 15 reaches location 78. In this case, the prime mover 74 will not be activated. Also, a container 15 disposed within the same slot 18 on the disk 16 but in the loading lane 30 will not be moved from the loading lane 30 to the process lane 28 when the relevant slot 18 reaches location 48.
In an alternative embodiment shown in FIGS. 13 and 19, the disk 16 is constructed to facilitate removal of a container 15 from the process path 10. In this embodiment, the slots 18 on the disk 16 include an enlarged container 15 removal area 82. Also, a diverter 84 is disposed in the process lane 28 adjacent to the location 78. The diverter 84, along with movement of the disk 16, urges the container 15 radially outward with respect to the disk 16 toward the container removal area 82 of the slot 18. The container removal area 82 is wider than the remainder of the slot 18 such that, when the container 15 reaches the container removal area 82 of the slot 18, gravity causes the container 15 to fall from the disk 16 and the process path 10 through the aperture 80 and into the waste receptacle. However, this embodiment does not allow a container 15 to pass the location 78 and still remain with the disk 16. But, if it were desirable to allow the container 15 to remain with the disk 16 in this embodiment, then the diverter 84 may be replaced with a prime mover, similar to the prime mover 44, to move the container 15 within the slot 18 toward the container removal area 82.
Another construction of the disk 16, the slot 18 and the container removal area 82 is shown in FIG. 19. This construction functions in a manner substantially similar to that of FIG. 13. It is to be noted that, in the embodiment illustrated in FIG. 19, an end of the process lane 28 is defined by the aperture 80.
Additional features may be incorporated into the process path 10 as desired. For example, liquid level sensing devices, such as radio frequency liquid level sense devices and the like, may be incorporated at positions along the process path 10 where liquid movement may occur. Also, any suitable structures, such as any of those disclosed in U.S. Pat. Nos. 5,358,691, 5,536,471 and 5,482,861 may be added, sometimes with appropriate modifications. Those patents are assigned to the assignee of the present case and the disclosures thereof are incorporated herein in their entirety by this reference.
It may also be desirable to construct the process lane 28 to reduce light in portions of the process lane 28. In one embodiment, the process lane 28 is constructed such that there is a radial divergence of that lane 28 prior to and following any position on the process path 10 where light, such as chemiluminescently generated light, measurements are performed. Such a radial divergence of the process lane 28 may increase the sensitivity of the light measurer by reducing introduction of stray or ambient light into the light measuring position of the process lane 28.
The process path automated described above allows sequential automated performance of multiple determination of item of interest process steps. The motion of a container 15 along the process lane 28 may be executed in discrete steps, that is discrete with respect to time and with respect to position along the process lane 28. At regular time intervals, such as about 18 seconds, the disk 16 rotates a distance substantially equal to the angular distance between two adjacent slots 18. This rotation causes each container 15 to move to the position along the process path 10 previously occupied by the container 15 in the adjacent slot 18. The disk 16 and the container 15 remain stationary for a remainder of the regular time period prior to the next rotation or indexing of the disk 16. The process lane 28 may be considered as having a fixed number of process positions, positions at which a process step comprising the determination of an item of interest in a sample occur, equal to the number of slots 18 in the disk 16.
In the examples described here, there are 112 slots 18 in the disk 16, and consequently the process lane 28 may be considered as having 112 process positions. The total processing time of a container 15 and its contents may be thought of as integral multiples of the index period. For example, if the index period is 18 seconds, a container 15 in the 10th process position has undergone a total of 180 seconds of processing. Similarly, a process step that is performed over 20 process positions takes a total of 360 seconds of process time on an individual container 15.
An example of process steps that may be performed during determination of an item of interest in a sample may be described by specifying the process position at which each process step occurs, as is provided in the following examples. This example may be more easily understood with reference to FIG. 16. The dotted line 129 indicates a boundary of a support on which the process path 10 is mounted.
A reagent carousel 131 is located substantially concentrically with the process path 10 and is rotatable. The reagent carousel 131 may include one or more carousels and may provide for axial rotation of individual containers, i.e. magnetic microparticle containers, disposed thereon. In one embodiment, the reagent carousel 131 may include multiple substantially concentric carousels to provide simultaneous and/or shared access of multiple containers by multiple pipette assemblies, such as assemblies 128 and 134. Such an arrangement may facilitate performance of the Formats discussed later. The reagent carousel 131 may be constructed substantially similarly to the structure disclosed in GB 2,081,118B issued on Sep. 7, 1983, with appropriate, well known bearings and gear trains being provided as and where needed (See FIG. 24B), as disclosed on Page 3, lines 86-91 of that patent. In an exemplary embodiment, the carousel 131 may be No. 77829-101 available from SPM/Portland of Hillsboro, Oreg., with appropriate motors available from Pacific Scientific, gears from Turnamatic of Richardson, Tex. and SPM/Portland and sensors from Aromat of Rolling Meadows, Ill.
The reagent carousel 131 may be maintained within a thermostatically controlled environment The thermostatically controlled environment may be provided by an air cooling unit which provides forced cooled air to a housing 133 (FIGS. 29 and 30) containing the reagent carousel 131. In an exemplary embodiment, the housing 133 may be similar to No. 76848 available from General Pattern of Blaine, Minn. This may reduce evaporation of fluid from the containers held on the reagent carousel 131. To further reduce evaporation, open mouths of the containers may be fitted with a seal 184 as shown in FIG. 25. The seal 184 may be made of a polymeric material, such as an elastomer and the like, and may include a slit 186 for allowing a pipettor access to the interior of the container.
In one embodiment, the reagent carousel 131 supports a plurality of reagent containers. These containers may be of at least four types, such as microparticle, conjugate, determination specific diluent and pretreatment, dependent upon the type of reagent contained therein. FIGS. 22, 23A, 23B and 23C give two exemplary configurations of the containers. A bottom portion 174 of the containers 176 (FIG. 22) and 177 (FIGS. 23A, 23B and 23C) is constructed to fit with mating portions of the reagent carousel 131.
As shown more clearly in FIGS. 24A and 24B, the bottom portion 174 of the container 177 bears a projection 178 which engages a complementary portion 188 of the reagent carousel 131. The engagement between the projection 178 and the portion 188 of the reagent carousel 131 provides a user who is placing the container 177 on the reagent carousel 131 with positive feedback, i.e. tactile feel, indicative of proper positioning of the container 177 with respect to the carousel 131.
As shown in FIG. 24B, the portion 188 of the carousel 131 is operatively connected by a shaft 191 with a drive gear 190 which drivingly engages a gear 202 which is connected with a prime mover (not shown). The gear 202 engages all drive gears 190 associated with the carousel 131. Operation of the prime mover moves the gear 202 which, in turn, moves the gear 190. Movement of the gear 190 causes axial rotation, which may be bi-directional, of the portion 188 and the container 177. The shaft 191 also electrically contacts a plate 204 which is electrically connected with a conductor 206. In this manner, the plate 204 and the conductor 206, and possibly the portion 188 of the carousel 131, if it is electrically conductive, comprise a portion of a radio frequency liquid level sense mechanism with determines a fluid level inside the container 177.
To further facilitate manipulation of the container 177, a substantially annular rib 180 (FIGS. 23A, 23B and 23C) may be provided on an outer surface of the container 177. Also, if it were desirable to maintain the container contents in a substantially homogeneous state, i.e. magnetic particles substantially uniformly dispersed in a liquid medium, then at least one fin 182 (FIGS. 24A and 24B) may be provided on an interior, fluid facing surface of the container 177 to agitate container contents upon axial rotation, as discussed above, of the container 177.
Illustrating constructions of the containers and seals with specific examples, the containers may be made from DOW 30460M HDPE or Chevron 90512 HDPE with a finish of SPI A3. The fins 182 may have a finish of SPI C1. The seals may be made from Lexington Medical 3401005 EPDM. The containers may have a neck inner diameter measuring about 1.069 inches. The rib may have a thickness of about 0.025 inches, a width, from an inner wall of the container, measuring about 0.31 inches, a top geometry measuring about 45 degrees, and a bottom geometry tapering to a center at an angle of about 48 degrees. The seal may have a diameter of about 1.094 inches when installed with a container, a maximum thickness of about 0.070 inches at a centerline of the seal, and a reinforced hinge section measuring about 0.025 inches thick by about 0.062 inches deep from an underside of a pipettor contact area on the seal The slit on the seal may comprise two slits having a length of about 0.5 inches through a center of the seal and offset about 90 degrees from each other.
To facilitate identification of the containers, at least some of the containers may bear a label 133A, 133B, or 133C, substantially similar to those shown in FIGS. 21A, 21B and 21C. The labels 133A, 133B and 133C include a high density data carrier 135A, 135B and 135C, respectively, which includes information to facilitate performance of the determinations.
In a specific embodiment, the high density data carrier 135A, 135B and 135C is a two dimensional bar code utilizing PDF 417 technology to provide desired data capacity. This technology allows for inclusion of more information than a common one dimensional bar code. Usage of such a high density data carrier 135A, 135B and 135C provides structural flexibility, i.e. individual containers for a given determination do not have to be physically joined together. The data carrier 135A, 135B and 135C contains information desirable for performance of a given determination. This information may include master lot number, container lot number, container contents, i.e. reagent, lot number and expiration date, calibration curve data, container contents type, etc. The information may also contain a serial number specific to the particular container to facilitate tracking of process path 10 resources.
In the illustrated embodiment, the data carrier 135A is used with magnetic microparticle containers and holds approximately 185 characters of information. The data carrier 135A is approximately 1.5 inches tall and about 0.75 inches wide, as viewed by the bar code reader. Because the microparticle container is rotated as discussed above, this rotation may be utilized while reading the data carrier 135A. In this case, the orientation of the data carrier 135A with respect to the bar code reader may not be important.
The data carriers 135B and 135C of the illustrated embodiment comprise two dimensional bar codes containing about 15 characters of information each. The data density of the carrier 135B and 135C is adjusted to allow the carrier 135B and 135C to be about 0.7 inches high. Furthermore, the data carrier 135B and 135C is printed with error correction, X bar, Y bar and a column count that allows the carrier 135B and 135C to be about 3.125 inches wide. In this manner, the data carrier 135B and 135C can be disposed along an outer circumference of a container such that the carrier 135B and 135C is accessible to the bar code reader through approximately 220 to approximately 270 degrees of visibility, depending on container size. Alternatively, instead of the carrier 135B which includes only one bar code, the data carrier 135C includes a plurality of repetitions of a similar, but narrower in form bar code with gaps between adjacent code repetitions. Additionally, various modifications of the data carriers 135A, 135B and 135C are also possible. For instance, one dimensional bar codes could be used, but the surface area of the one dimensional bar code would have to be sufficient for the amount of data contained in the two dimensional bar code.
EXAMPLE
DETERMINING AN ITEM OF INTEREST IN A SAMPLE
The process path 10 illustrated in FIG. 1 is utilized to perform a sequence of process steps, executed with a index period of about 18 seconds. Each index step comprises about 1 second of rotation of the disk 16 (and consequent motion of the containers 15 disposed within the disk 16) and about 17 seconds during which the containers 15 are stationary at their respective process positions. The process step performed at each process position is as follows:
______________________________________ProcessPosition Process Step Description______________________________________ 1 Container 15 load Container 15 moved from loading lane 30 to process lane 28 as required 1 Sample Pipettor Sample deposited into container 15 by pipetting system 128. The sample may be obtained from position 130A or 130B which are located on appropriate conveyors, sample handlers or structures associated with a laboratory automation system 2 Reagent Pipettor 1 Reagent obtained from reagent carousel 131 deposited into container 15 by pipetting system 132. Liquid present in the pipetting system 132 may also be added to the container 15. 3 Mixer Contents of container 15 are mixed by a device 86 imparting motion to the container 15 4-23 Incubation Contents of container 15 are incubated at a controlled temperature, about 37 degrees Celsius24 Sample Pipettor Container contents may be aspirated from container 15 by pipetting system 128 for deposition into a second container 15 at position 125-39 Incubation Contents of container 15 are incubated at a controlled temperature40 Bypass region 58A Container 15 is selectively start positioned at entry to performance lane 62 or avoidance lane 64 of bypass region 58A41 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation and fluid addition42 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition43 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition44 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation and container 15 contents aspiration 45.5 Bypass region 58A Performance lane 62 and avoidance end lane 64 of bypass region 58A merge (midway between positions 45 and 46)46 Container 15 load New containers 15 are loaded into into loading lane loading lane 30 3048 Reagent Pipettor 2 Reagent selectively deposited into container 15 by pipetting system 13449 Mixer Contents of container 15 are mixed by a device 86 imparting motion to the container 1550-62 Incubation Contents of container 15 are incubated at a controlled temperature63 Bypass region 58B Container 15 is selectively positioned at entry to performance lane 62 or avoidance lane 64 of bypass region 58B64 Wash zone 2 Container 15 in performance lane 62 undergoes magnetic separation and fluid addition65 Wash zone 2 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition66 Wash zone 2 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition67 Wash zone 2 Container 15 in performance lane 62 undergoes magnetic separation, and container 15 contents aspiration68 Bypass region 58B Performance and avoidance lanes end 62 and 64 of bypass region 58B merge69-70 Incubation Contents of container 15 are incubated at a controlled temperature71 Reagent Pipettor 2 Reagent selectively deposited into container 15 by pipetting system 13472 Mixer Contents of container 15 are selectively mixed by a device 86 imparting motion to the container 1573-86 Incubation Contents of the container 15 are incubated at a controlled temperature75 Motor/Encoder Gear 22 on prime mover 24 engages teeth 20 on disk 16 at this position 77.5 Home Sensor Electrical, magnetic, optical, or other sensor 136 is present to generate signal corresponding to the position of the disk 1686 Bypass region 58C Container 15 is selectively positioned at entry to performance lane 62 or avoidance lane 64 of bypass region 58C87 Wash zone 3 Container 15 in performance lane 62 undergoes magnetic separation and fluid addition88 Wash zone 3 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition89 Wash zone 3 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition90 Wash zone 3 Container 15 in performance lane 62 undergoes magnetic separation, and container 15 contents aspiration91 Bypass region 58C Performance and avoidance lanes end 62 and 64 of bypass region 58C merge91-93 Incubation Contents of container 15 are incubated at controlled temperature94 Pre-Trigger and Reagent added to container 15 and Mixer mechanically mixed95-97 Incubation Contents of container 15 are incubated at controlled temperature98 Shutter, reader, Indicator reaction (such as and trigger chemiluminescent reaction) triggered and read with magnetic particles pulled out of solution with magnet. Shutter blocks light.99 Magnet Magnetic particles are held at a wall of the container 15100 Liquid Waste Magnetic particles are held at a Aspirate wall of the container 15 and all liquid in container 15 is aspirated and discarded109 Container 15 unload Container 15 selectively removed from process lane 28111 Container 15 unload System optically verifies that sensor slot 18 in process lane 28 is vacant prior to loading of second container 15______________________________________
Adding more specificity to the example, in a particular embodiment, the determination of an item of interest in a sample is an immunoassay. When the process path 10 is used to perform an immunoassay, the container 15 is moved into the process lane 28 at position 1. Also at position 1, a known quantity of sample (for example, 50 .mu.l of blood) is deposited into the container 15 by a pipetting system 128. The pipetting system 128 comprises a pipettor, which may be substantially similar to the pipettors 116A, 116B and 116C, mounted on an arm for movement up and down and angularly, as shown in FIG. 16.
After indexing the container 15 to position 2, a known quantity of a first reagent, possibly along with an amount of fluid present in the pipetting system 132, is deposited into the container 15 by a second pipetting system 132. The first reagent may contain magnetically responsive microparticles coated with antibodies or other binding substances that specifically bind to the item of interest in the sample. The first reagent may be added with an assay specific diluent. In some cases, the first reagent and a conjugate, possibly along with an amount of fluid present in the pipetting system 132, may be added at position 2.
At position 3, a mechanical device 86 (illustrated in FIG. 12) is provided to mechanically move the container 15 and cause mixing of the contents of the container 15. The mechanical mixing device 86 includes a bore 88 formed within a body 89, which is eccentrically formed in the illustrated embodiment, that moves axially and rotatably under the influence of a prime mover 90 connected with the body 89. When the prime mover 90 is activated, the body 89 rotates clockwise, and a protrusion 92 connected with the prime mover 90 moves within a slot 94 in a second body 96. The second body 96 rotates freely about a drive shaft of the prime mover 90.
As the protrusion 92 moves within the slot 94, the body 89 and the bore 88 move toward the bottom 40 of the receptacle 15 as the body 89 rotates. When the body 89 and the bore 88 move toward the container 15, the bore 88 engages the bottom 40 of the container 15 and imparts an orbital (but not rotational) motion to the bottom 40 of the container 15. The portions of the container 15 adjacent the top surface 42 remain relatively stationary within the slot 18 in the disk 16.
The mechanical motion imparted to the container 15 mixes the sample with the first reagent. After the contents of the container 15 have been mixed for a predetermined time period, the prime mover 90 rotates its drive shaft counterclockwise, causing the protrusion 92 to move in an opposite direction within the slot 94, thereby moving the first body 89, the bore 88 and the second body 96 away from the bottom 40 of the container 15.
Illustrating further with a specific example, in one embodiment, the body 89 is made of PEEK with a black finish, the protrusion 92 is made of AISI 301 stainless steel with a #10 passivated finish, the second body 96 is made of Acetron GP with a white finish and the slot 94 has a #32 finish. The bore 88 in the body 89 is offset from an axis of the body 89 and has a radius of about 0.020 inches. An interface between the body 89 and the container 15 provides a minimum of about 0.05 inches of eccentric rotation of the container 15. The slot 94 provides a rise of about 0.315 inches over a rotation of the second body 96 of about 226.8 degrees. The prime mover 90 is a 3 phase, 8 pole, Y connected DC brushless motor P/N DR538-504 available from Shinano Kenshi of California. The prime mover 90 is supplied with a 36 Volt potential and operates substantially within the range of about 500 to about 5500 rpm's with a torque constant of about 620 g*cm/A.
The container 15 is freed from the bore 88 and processing of the container 15 contents continues. Subsequently, the container 15 contents is incubated for a predetermined time period.
At position 24, depending upon the particular item of interest in the sample to be determined, the first pipetting system 128 may withdraw a portion of the contents of the container 15 for deposition into another container 15 located at position 1. This may be appropriate when a particular determination requires pretreatment, such as pre-heating, heated incubation with a first reagent prior to second reagent introduction, and the like, prior to introduction of magnetically responsive microparticles comprising the first reagent
At position 37, the process path 10 selectively positions the container 15 for performing or avoiding a series of magnetic separation and wash steps. Structures for performing the wash and separation comprise a wash station 114, shown in FIGS. 14 and 15.
Each wash station 114 includes a plurality, 3 in the illustrated embodiment, of movable pipettors 116A, 116B and 116C and at least one stationary nozzle (not shown) for moving fluids at least one of into and out of the container 15. In some embodiments, the movable pipettors 116A, 116B and 116C may be used to move fluids out of the container 15 while the at least one stationary nozzle moves fluid into the container 15. Sensors, such as thermistors and the like, may be operatively associated with the pipettors 116A, 116B and 116C to verify fluid movements.
The pipettors 116A, 116B and 116C move liquids both into and out of the container 15 whereas the nozzle only moves liquid into the container 15. The movable pipettors 116A, 116B and 116C are connected to a common base plate 118 which moves with respect to the cover 12 under the influence of a prime mover 120, such as a stepper motor and the like. Responsive to the prime mover 120, the pipettors 116A, 116B and 116C move into and out of the container 15. Suitable fluid delivery conduits, not shown, are connected with the pipettors 116A, 116B and 116C and the nozzle. The pipettors 116A, 116B and 116C are spring-loaded to facilitate their replacement and to cushion any contact between the pipettors 116A, 116B and 116C and another surface, such as the bottom 40 of the container 15 and the like.
The pipettors 116A, 116B and 116C are movable to remove fluid from the container 15. Because the item of interest is connected with the magnetic particles, a magnet assembly 122 is also included at the wash station 114. The magnet assembly 122 is disposed in a receptacle 124 in the base 14. The magnet assembly 122 includes a portion of the performance lane 62 and holds a plurality of permanent magnets 126. In an exemplary embodiment, the assembly 122 is made from 6061 T6 aluminum with a finish of MIL-A-63576 Type I and the magnets 126 are neodymium Iron Boron (NdFeB) magnets with a residual flux density (Br) substantially within the range of about 12.1 to about 13.2 KG, a coercive force (Hc) substantially within the range of about 11.0 to about 12.0 KOe, an intrinsic coercive force (Hci) substantially within the range of about 17.0 to about 19.0 KOe and a total energy product (BHmax) substantially within the range of about 34.0 to about 41.0 MGOe. The field intensity of the magnets 126 at a distance of about 0.030 inches from the container 15 is about 4470 Gauss and at a distance of about 0.176 inches from the container 15 is about 1570 Gauss.
At the wash station 126, the magnets 126 hold the magnetic particles, and thereby the item of interest, against a side wall 36A or 36B of the container 15. This allows removal of contents of the container 15 other than the magnetic particles and the item of interest bound to the magnetic particles. In some constructions, the pipettors 116A, 116B and 116C may be positioned such that the pipettors 116A, 116B and 116C move substantially along a central axis of elongation of the container 15, may be biased away from a side wall 36A or 36B against with the magnetic particles are held, or otherwise constructed to reduce the chances of the pipettors 116A, 116B and 116C removing magnetic particles and the item of interest bound to the magnetic particles from the container 15.
In an exemplary embodiment, the pipettors 116A, 116B and 116C are made from Inconel. The pipettors 116A, 116B and 116C are disposed such that longitudinal center lines of the pipettors 116A, 116B and 116C are offset a distance measuring about 0.029 inches from a center line of the containers 15 into which the pipettors 116A, 116B and 116C are inserted. This offset distances the pipettors 116A, 116B and 116C from magnetic particles within the containers 15 When the pipettors 116A, 116B and 116C dispense fluid into the containers 15, the pipettors 116A, 116B and 116C are located a distance measuring about 0.342 inches from a side wall of the containers 15 adjacent the magnets 126 The pipettors 116A, 116B and 116C are mounted with springs so as to absorb up to 0.1 inches of overdrive. The pipettors 116A, 116B and 116C are fluidly connected with a valve which allows for bubble flushing without use of a container 15. The stationary nozzle is made of 0.031 inch inner diameter PEEK tubing. The base plate 118 is a two piece, thermally bonded assembly of acrylic with a clear Iridite finish on top and an opaque finish on the bottom to allow fluid visibility and light protection for a chemiluminescence reader.
If, for a particular determination, magnetic separation and washing is required at position 37, the container 15 is moved to the performance lane 62. Containers 15 in the performance lane 62 undergo, at each processing position between 41 and 44, magnetic separation (effected by permanent magnets 126 at fixed locations adjacent to the performance lane 62), fluid aspiration, and fluid dispensing, performed by fluid handling devices introduced through an opening 98 (FIG. 1) in the cover 12. In one embodiment, one of these wash stations (position 41) includes only a magnetic separation and fluid dispensing step that introduces a wash buffer to the container 15. In some cases, wash buffer or other fluid is added such that the amount of fluid present within the container 15 facilitates separation (magnetic) of the particles from the fluid in the container 15. At positions 42 and 43, separation, fluid aspiration, and fluid dispensing occur. In position 44, the magnetic particles are separated from the fluid in the container 15 by magnets 126 and fluid is aspirated. In this example, these steps would remove substantially all substances within the container 15 that have not bound to binding conjugate elements on the magnetic particles deposited as the first reagent. Containers 15 within the avoidance lane 64 are undisturbed and continue incubation. The performance and avoidance lanes 62 and 64 merge between positions 45 and 46.
A second reagent may be deposited into the container 15 at location 48 (FIG. 4) by a third pipetting system 134, again followed by a mechanical device 86 at position 49 to mix the container 15 contents. The second reagent may include an indicator substance, such as a chemiluminescent substance, linked to binding elements that also bind to the item of interest (remaining occurrences of which are bound to the magnetic particles of the first reagent). The contents of the container 15 are incubated at positions 50-59.
The second bypass region 58B begins at position 60, where the container 15 may selectively automatically undergo a set of magnetic separations, fluid aspirations, and fluid dispensing steps.
The third pipetting system 134 may deposit a third reagent into the container 15 at position 71, with subsequent mixing at position 72 and incubation between positions 73 and 86.
The third bypass region 58C begins at position 86, where the container 15 may selectively automatically undergo a set of magnetic separations, fluid aspirations and fluid dispensing steps.
In one embodiment, where it is assumed that substantially a majority of the containers 15 will undergo magnetic separation, fluid aspiration, and fluid dispensing at positions 87-90, no bypass region 58C may be provided at these locations. For example, these step would cause the removal of substantially all indicator (chemiluminescent) substances that are not bound to the magnetic particles (via the analyte of interest), yielding a container 15 holding indicator substance in an amount indicative of the amount of the item of interest in the initial sample deposition. However, in some determinations, it is desirable to avoid those process steps.
A pretrigger reagent may be deposited by a fluid dispensing device at position 94.
A fluid dispensing device will deposit a triggering agent at position 98, which causes the indicator reaction to occur. For example, a chemiluminescent substance releasing reagent may be deposited at position 94, which causes the release of the indicator (chemiluminescent) substance from the magnetic particles.
The contents of the container 15 are incubated between positions 95 and 97, inclusive.
Position 98 may also include a magnet, which separates or removes substantially all of the magnetic particles from the fluid within the container 15. The magnet holds substantially all of the magnetic particles against a side wall 36A or 36B of the container 15 prior to reading of light from the chemiluminescent substance. Preferably, all of the magnetic particles are removed from a path of chemiluminescent photons from the chemiluminescent substance, which remains in solution in the fluid in the container 15, to a light detection apparatus 138. This read step is substantially similar to that described in EP 0 371 265 B1 issued Jan. 1, 1994. The introduction of the triggering reagent would initiate a chemiluminescent reaction which would be detected and quantified by an optical detection system (not shown) such as a photomultiplier tube or photon counting system.
In an exemplary embodiment, the apparatus 138 may comprise a reader assembly such as No. 78262 available from Thorn EMI of Rockaway, N.J., a photomultiplier tube such as No. 78252-101 available from Hammamatsu of Middlesex, N.J. and a substantially light-tight shutter operable by a plunger such as No. 78200-101 available from Ironwood Industries of Libertyville, Ill. and a motor such as No. 78851-101 available from Haydon Switch & Instrument of Waterbury, Conn.
The embodiment described in the following examples demonstrates its utility in processing multiple assays of different formats and timing requirements within a common process path 10. In these examples, the embodiment described enables the execution of at least the following four assay formats, the first three of which may be executed simultaneously with no degradation in processing capacity.
______________________________________Format AStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (18 minutes) 4-63Separation and wash 64-67Second reagent introduction and 71-72mixingSecond incubation (4 minutes) 73-86Separation and wash 87-90Pretrigger introduction and 94mixingThird incubation (1 minute) 95-97Trigger and read 98______________________________________
As an example, Format A may be used to determine at least the following items of interest: antibodies to HCV, antibodies to HIV 1/HIV 2, antibodies to hepatitis B core antigen (HBcAb), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), Hepatitis B Surface Antigen (HBsAg), antibodies to Hepatitis B Surface antigen (HBsAb), alpha-fetoprotein (AFP), Total prostate specific antigen (Total PSA), Free PSA, Thyroid stimulating Hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), beta human chorionic gonadotropin (B-hCG), Free Thyroxine (Free T4), Free triiodothyronine (Free T3), Total T4, Total T3, Prolactin and Ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format. For instance, this format may also be used to determine beta human chorionic gonadotropin (B-hCG), prolactin and ferritin.
______________________________________Format BStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (11 minutes) 4-40Separation and wash 41-44Second reagent introduction and 48-49mixingSecond incubation (11 minutes) 50-86Separation and wash 87-90Pretrigger introduction and 94mixingThird incubation (1 minute) 95-97Trigger and read 98______________________________________
As an example, Format B may be used to determine an item of interest in a sample where a relatively increased degree of sensitivity, as compared with some other formats, is desired. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.
______________________________________Format CStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (11 minutes) 4-40Separation and wash 41-44Second reagent introduction and 48-49mixingSecond incubation (4 minutes) 50-63Separation and wash 64-67Third reagent introduction and 71-72mixingThird incubation (4 minutes) 73-86Separation and wash 87-90Pretrigger introduction and 94mixingFourth incubation (1 minute) 95-97Trigger and read 98______________________________________
As an example, Format C may be used when the item of interest relates to hepatitis, such as determinations for anti-M, HBcAb-M and HAVAb-M.
______________________________________Step Position______________________________________Format DSample introduction 1First reagent introduction and 2-3mixingFirst incubation (7 minutes) 4-23Transfer to second container 15 24in position 1Second reagent introduction and 2-3mixingSecond incubation (11 minutes) 4-40Separation and wash 41-44Third reagent introduction and 48-49mixingThird incubation (4 minutes) 50-63Separation and wash 64-67Fourth reagent introduction and 71-72mixingFourth incubation (4 minutes) 73-86Separation and wash 87-90Pretrigger introduction and 94mixingFifth incubation 95-97Trigger and read 98Format ESample introduction 1First reagent 2-3introduction and mixingFirst incubation (7 4-23minutes)Transfer portion of 24container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 24-63contents continues firstincubation (11 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 passes 64-67through bypass region 58BSecond container 15 first 4-63incubation (18 minutes)Introduction of fourth 71-72reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 64-67separation and washFourth incubation (4 73-86minutes - optional) offirst container 15Third reagent 71-72introduction into secondcontainer 15 and mixingFirst container 15 passes 87-90through bypass region 58CThird incubation (4 73-86minutes) of secondcontainer 15Pretrigger introduction 94into first container 15and mixingSeparation and wash of 87-90second container 15Trigger and read value 1 98(Total Hb) from firstcontainer 15Pretrigger introduction 94into second container 15and mixingTrigger and read value 2 98(GlyHb)______________________________________ ##STR1##- For example, in Format E, it is possible to modify the format by disregarding the first container 15 after the portion of the container 15 contents has been transferred (Position 24) to the second container 15. In that case, Format E may be used to determine, for example, folate and vitamin B12.
______________________________________Format FStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation (7 4-23minutes)Transfer portion of 24container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 24-63contents continues firstincubation (11 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 passes 64-67through bypass region 58BSecond container 15 first 4-40incubation (11 minutes)Introduction of fourth 71-72reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 41-44separation and washFourth incubation (4 73-86minutes-optional) offirst container 15Third reagent 48-49introduction into secondcontainer 15 and mixingFirst container 15 passes 87-90through bypass region 58CThird incubation (11 50-86minutes) of secondcontainer 15Pretrigger introduction 94into first container 15and mixingSeparation and wash of 87-90second container 15Trigger and read value 1 98(Total Hb) from firstcontainer 15Pretrigger introduction 94into second container 15and mixingTrigger and read value 2 98(GlyHb)______________________________________ ##STR2##- This format may be used, for example, to determine at least one of tota and glycated hemoglobin. Also, this format may be modified by disregarding the first container 15 as in Format E.
______________________________________Format GStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation (7 4-23minutes)Transfer portion of 24container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 24-63contents continues firstincubation (11 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 64-67separation and washSecond container 15 first 4-63incubation (18 minutes)Introduction of fourth 71-72reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 64-67separation and washFourth incubation (4 73-86minutes-optional) offirst container 15Third reagent 71-72introduction into secondcontainer 15 and mixingFirst container 15 87-90separation and washThird incubation (4 73-86minutes) of secondcontainer 15Pretrigger introduction 94into first container 15and mixingSeparation and wash of 87-90second container 15Trigger and read value 1 98(Total Hb) from firstcontainer 15Pretrigger introduction 94into second container 15and mixingTrigger and read value 2 98(GlyHb)______________________________________ ##STR3##- As an example, this format may also be modified as may be done with Format F. With that modification, this Format may be used to determine progesterone, testosterone and estradiol.
______________________________________Format HStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation 4-86Separation and wash 87-90Pretrigger introduction 94and mixingSecond incubation 95-97Trigger and read 98______________________________________
As an example, this format may be used to determine, among other things, beta human chorionic gonadotropin (B-hCG), prolactin, progesterone, testosterone, estradiol and ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.
______________________________________Format IStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2introduction into firstcontainer 15, portion offirst container 15contents moved intopipettor, remainder ofcontainer continues onprocess lane 28,bypassing all washstations, to Position 71First reagent 2-3introduction into secondcontainer 15 and mixingFirst incubation of 4-23second container 15Second container 15 first 24-63incubation (18 minutes)Introduction of second 71-72reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 64-67separation and washFourth incubation (4 73-86minutes - optional) offirst container 15Third reagent 71-72introduction into secondcontainer 15 and mixingFirst container 15 passes 87-90through bypass region 58CThird incubation (4 73-86minutes) of secondcontainer 15Pretrigger introduction 94into first container 15and mixingSeparation and wash of 87-90second container 15Trigger and read value 1 98(Total Hb) from firstcontainer 15Pretrigger introduction 94into second container 15and mixingTrigger and read value 2 98(GlyHb)______________________________________ ##STR4##- As an example, in Format I, it is possible to modify the format by disregarding the first container 15 after the portion of the container 15 contents has been transferred (Position 24) to the second container 15. In that case, Format I may be used to determine, for example, folate and vitamin B12.
______________________________________Format JStep Position______________________________________Sample introduction into 1container 15, possiblywith diluent fluidFirst reagent 2-3introduction and mixingFirst incubation (27 4-93minutes)Pretrigger introduction 94and mixingSecond incubation (1 95-97minute)Trigger and read 98______________________________________
As an example, Format J may be used to determine, among other things, total hemoglobin.
The embodiments described herein also allow for sample pretreatment which may be performed in at least two ways, indicated as Formats K and L. During performance of sample pretreatment, fluid present in the containers 15 indicated may be processed, after they are no longer significant in the pretreatment steps, in any appropriate manner, such as any of the Formats discussed above. Also, as will become clear later on, both Formats K and L are substantially similarly applicable to the other embodiments of the process path 10 discussed below.
______________________________________Format KStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2-3introduction and mixingFirst incubation (7 4-23minutes)Transfer portion of 24contents of firstcontainer 15 to secondcontainer 15 in PositionSecond reagent 2-3introduction to secondcontainer 15 and mixing(optional)Transfer portion of 24contents of secondcontainer 15 to thirdcontainer 15 in Position1Third reagent 2-3introduction to thirdcontainer and mixing(optional)______________________________________
As an example, the third container 15 may be processed according to at least one of Formats A (to determine, among other things, folate), B, C, H and J.
______________________________________Format LStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2-3introduction and mixingFirst incubation (7 4-23minutes)Transfer portion of 24contents of firstcontainer 15 to secondcontainer 15 in PositionSecond reagent 2-3introduction to secondcontainer 15 and mixing(optional)______________________________________
As an example, the second container 15 may be processed according to at least one of Formats A (to determine, among other things, folate, vitamin B12, confirm HBsAg), B, C, H and J.
In each of the formats discussed above, it is possible to move contents of a first container 15 at Positions 2 or 24 into a second container 15 at Position 1. Thereafter, the first container 15 may or may not be ignored.
It is to be remembered, as pointed out earlier, that the steps of one format may be mixed with steps of another format to arrive at yet further formats. Also, it is to be remembered that the construction of the process path 10, and its elements and supporting components, allow for selective automated performance (i.e. a particular step may or may not be performed, as desired) of the above-described steps.
These examples demonstrate usefulness of the described embodiments in controlled processing of determinations of items of interest in a sample within a common process path 10.
As discussed earlier, multiple process paths 10 may be connected to meet specific needs. If the process path 10 were to perform approximately 200 determinations per hour, and if an analyzer (FIG. 29) that performed 400 determinations per hour were needed, then two process paths 10 could be connected. One way of doing is described with reference to FIGS. 17, 29 and 30.
As FIG. 17 illustrates, the process path 10 would be located in space 140. To supply samples to the process path 10, a load track 142 and a conveyor 146 are provided connected to a frame 148 defining the space 140. In some embodiments, at least one of the load track 142, the conveyor 146 and an unload track 192 may be provided with a cover 194 (FIG. 30). A carrier 150 supporting multiple sample tubes 152, which may be any suitable tubes, rides along both the load track 142 and the conveyor 146. Both the load track 142 and the conveyor 146 move the carrier 150 as indicated by the arrows. A transfer mechanism 154, such as a solenoid (e.g. linear actuation) driven arm and the like, shifts the carrier 150 from the load track 142 to the conveyor 146.
The carrier 150 moves along the conveyor 146 until the carrier 150 is stopped by a retention member 156, which is, in the illustrated embodiment, a stepper motor driving a star wheel which mates with the carrier 150. The pipetting system 128 accesses sample at the position 130B and supplies that sample to a container 15 on the process path 10. Of course, suitable identification structures, such as bar codes on the sample tubes 152 and a bar code reader, can be provided When the pipetting system 128, or any of the pipetting systems 128, 132 or 134 access a fluid, pipetting system pressure can be monitored as described in commonly owned U.S. patent application, Ser. No. 08/572,835 filed on Dec. 14, 1995. The disclosure of that application is incorporated herein in its entirety. Appropriate liquid level sense devices, such as radio frequency based devices and the like, may also be located in suitable positions.
In an exemplary embodiment, the load track 142 may be No. 77325-101 and the conveyor 146 may be No. 77425-101 both available from Dorner Manufacturing of Hartland, Wis. The unload track 192 may be No. 77525-101 available from SPM/Portland of Hillsboro, Oreg. The retention member 156 may be No. 77476-101 available from Pacific Scientific of Elgin, Ill. The transfer mechanism 154 may comprise a solenoid such as No. 77952 available from Lucas/Ledex of Vandalia, Ohio, a belt such as No. 6R25-M225090 and a pulley such as No. A 6725-020DF0908 both available from Stock Drive Parts of New Hyde Park, N.Y., and a stepper motor such as No. P21NSXS-LSS-NS07 available from Pacific Scientific of Elgin, Ill.
In some cases, a level of sample in a sample tube 152 may be insufficient for access by the pipetting system 128. In these cases, the sample within the sample tube 152 may be moved by an operator into another container 208 shown in FIGS. 31A, 31B and 31C. The container 208 comprises a barrel 210 and a flange 212. The barrel 210 is dimensioned to fit within the sample tube 152 as shown in FIG. 31C. The flange 212 is offset from an outer diameter surface of the barrel 210 by a distance sufficient to accommodate any suitable sample tubes 152. In this way, sample can be moved from the sample tube 152 into the container 208 and the container 208 can be placed within the sample tube 152. The sample tube 152 bearing the container 208 may then be placed into the carrier 150. Because the sample is now in the container 208, the level of the sample is elevated with respect to the level of the sample in the sample tube 152, thereby facilitating sample access by the pipetting system 128.
In an exemplary embodiment, the container 208 may be made from Dow 666 polystyrene and is dimensioned to fit within sample tubes having outer diameters substantially within the range of about 0.4 inches through about 0.7 inches. The barrel 210 has an outer diameter measuring about 0.4 inches and a length of about 1.964 inches. The flange 212 has an outer diameter measuring about 0.776 inches, depends from an open end of the container 208 by a distance of about 0.216 inches and is offset from the outer diameter surface of the barrel 210 by a distance of about 0.258 inches.
In some embodiments, the load track 142 is removed and replaced by a sample supply conveyor having a similar retention member 156. If this were done, then the pipetting system 128 would access sample at position 130A. If this case, then, in additional embodiments, a carousel 189 may be operatively connected with the frame 148 by a connection member 193 as shown in FIGS. 26 and 27. The connection member 193 locates the carousel 189 with respect to the process path 10 such that the pipetting system 128 can also access containers on the carousel 189 at position 130B. The carousel 189 may be used, for instance, to house determination calibrators and controls and certain samples, such as emergency samples that need to be processed immediately. In an exemplary embodiment, the carousel 189 may be a 2 or 3 part injection molded polymeric (ABS, GE-Cycolac or the like) article constructed substantially similar to a TDx.RTM. unit dose carousel, an IMx Select.RTM. carousel (Abbott Laboratories, Abbott Park, Ill.) and the like.
In some instances, the retention member 156 may not retain the carrier 150 for sample access, but may allow the carrier 150 to move toward an end 158 of the conveyor 146 towards another process path 10. In this case, the frame 148 includes a connecting structure 160 for operatively coupling one process path 10 to another, or more specifically, one frame 148 holding one process path 10 to another frame 148 holding another process path 10. In an exemplary embodiment, the connecting structure 160 may be constructed such that two adjacent frames 148 are offset by a distance substantially within the range of about 0.25 inches to about 1.5 inches.
The connecting structure 160 comprises a first bracket 162 and a second bracket 164. The first bracket 162 is connected with one frame 148 and the second bracket 164 is connected with the another frame 148. To connect the frames 148, a fastener, such as a bolt and the like, is placed between aligned apertures 166 in the first and second brackets 162 and 164. Another fastener is inserted into slots 168 disposed on opposite ends of the brackets 162 and 164. The conveyors 146 supported by both frames 148 have sufficient tolerance such that more precise alignment of the frames 148 is not required. As a carrier 150 leaves an end 158 of one conveyor 146, the carrier 150 is supported by an opposing end 196 of an the adjacent conveyor 146. Once the carrier 150 reaches the end 158 of the last conveyor 146, the carrier 150 is moved to an unload track 192 (FIG. 29), constructed and operated substantially similarly to the load track 142, by another transfer mechanism 197, which may be substantially similar to the transfer mechanism 154.
The construction of the process path 10 is also adaptable in other ways to meet other requirements. For example, it may be desirable to provide a process path 10 that performs 100, 50 or any desired number of determination per hour. Viewing this requirement in another way, it may be desirable to provide a process path 10 that fits within a certain physical space, such as a table surface. To meet such requirements, the process path 10 may be scaled, i.e. altered in size or determinations per hour while still including elements discussed above, such as a bypass region, a mixing device, a pipetting system, a wash station and a reader.
Another embodiment is a process path 10.about., constructed to perform 100 determinations per hour, and is illustrated in FIGS. 20A and 20B. This embodiment utilizes elements substantially similar to those described above, hence the like reference characters The same index period and assay formats are used, thereby allowing the same reagents to be used. Because of the reduced number of determinations per hour, it is possible to reduce correspondingly the physical dimensions of the embodiment. For instance, whereas the process path 10 of the previous Figures comprises 112 positions, the process path 10.about. comprises about 55 positions. In another embodiment, which performs 50 determinations per hours the corresponding process path comprises approximately 32 positions.
Whereas the determinations performed with the process path 10 are completed without a container 15 passing the same location along the process lane 28 more than once, the containers 15 used with the process path 10.about. may pass the same location along the process lane 28 more than once. Depending upon the particular needs to be addressed, the process path may be modified such that a container 15 passes the same location along the process path any appropriate number of times. Of course, depending upon the particular employment, a given container 15 may be positioned in a different one of a performance lane 62 and an avoidance lane 64 of a given bypass region 58 at different times passing through the same bypass region 58 during a given determination.
Illustrating further by example, the following describes the procedures performed at each location along the process path 10.about. which performs 100 determinations in an hour. As noted above, a particular container 15 may pass a given location along the process path 10.about. more than once. Therefore, Process Position 1 indicates the first time the container 15 encounters Process Position 1, while Process Position 1' indicates the second time the container 15 encounters Process Position 1. Also, in similar fashion, Process Position 1" indicates the third time the container 15 encounters Process Position 1. Furthermore, the process path 10.about. is constructed such that once a container 15 reaches Process Position 46 a first time, the next Process Position reached by the container 15 may be Process Position 1', i.e. the container 15 moves from one end of the process path 10.about. to an opposite end of the process path 10.about..
In the illustrated embodiment of the process path 10.about., a second processing lane 170 is included. The second processing lane 170 may be located in any suitable position with respect to the processing lane 28 so that a container 15 can move between the process lane 28 and the process lane 170. In some embodiments, the position of the process lane 170 may be chosen to maintain the process path 10.about. within specified physical dimensions.
A prime mover, which may be substantially similar to the prime movers discussed earlier, is located, in an exemplary embodiment, adjacent position 46 along the process lane 28. This prime mover is operable to move a container 15 from the process lane 28 to the process lane 170 when desired, viz. for reading a determination reaction, removal of a container 15 from the process path 10.about., etc. The process lane 28 may be joined to the process lane 170 by suitable connection structures 172, such as those associated with a bypass region. In this manner, a container 15 may be selectively automatically moved between the process lane 28 and the process lane 170. Thus, upon reaching Process Position 46, a container 15 may move to Process Position 1 of the process lane 28, or, alternatively, may move from Process Position 46 of the process lane 28 to Process Positions 47 through 55 of the process lane 170. Once in the process lane 170, process steps detailed in the example below are performed. Of course, structures, similar to those discussed above, that perform those process steps are disposed along the process lane 170 which has sufficient dimensions to accommodate those structures.
______________________________________ProcessPosition Process Step Description______________________________________1 Container 15 load Container 15 moved from loading lane 30, if present, to process lane 28 as required1 Sample Pipettor Sample deposited into container 15 by pipetting system 128. The sample may be obtained from position 130A or 130B which are located on appropriate conveyors2 Reagent Pipettor 1 Reagent obtained from reagent carousel 131 deposited into container 15 by pipetting system 1323 Mixer Contents of container 15 are mixed by a device 86 imparting motion to the container 154-16 Incubation Contents of container 15 are incubated at a controlled temperature, about 37 degrees Celsius17 Bypass region start Container 15 is selectively positioned at entry to performance lane 62 or avoidance lane 64 of bypass region18 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation and fluid addition19 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition20 Wash zone W Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition21 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation, and container 15 contents aspiration22 Bypass region end Performance and avoidance lanes 62 and 64 of bypass region merge23-24 Incubation Contents of container 15 are incubated at a controlled temperature24 Sample Pipettor Sample may be aspirated from container 15 by pipetting system 128 for deposition into a second container 15 at position 125 Reagent Pipettor 2 Reagent obtained from reagent carousel 131 may be deposited into container by pipetting system 13226 Mixer Contents of container 15 are mixed by a device 36 imparting motion to the container 1527-39 Incubation Contents of container 15 are incubated at a controlled temperature40 Bypass region start Container 15 is selectively positioned at entry to performance lane 62 or avoidance lane 64 of bypass region41 Wash zone 2 Container 15 in performance lane 62 undergoes magnetic separation and fluid addition42 Wash zone 2 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition43 Wash zone 2 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition44 Wash zone 2 Container 15 in performance lane 62 undergoes magnetic separation and container 15 contents aspiration45.5 Bypass region end Performance lane 62 and avoidance lane 64 of bypass region merge (midway between positions 45 and 46)46 Process lane Container moves from Process transfer Position 46' of process lane 28 to Process Position 46 of process lane 17046-47 Incubation Contents of container 15 are incubated at a controlled temperature48 Pre-Trigger and Reagent added to container 15 and Mixer mechanically mixed49-51 Incubation Contents of container 15 are incubated at controlled temperature52 Shutter, reader, Indicator reaction (such as and trigger chemiluminescent reaction) triggered and read with magnetic particles pulled out of solution with magnet. Shutter blocks light.54 Liquid Waste Magnetic particles are held at a Aspirate wall of the container 15 and all liquid in container 15 is aspirated and discarded55 Container 15 unload Container 15 removed from process lane 28______________________________________
Given these modifications, it is possible to utilize determination formats that are substantially similar to those discussed previously. For the sake of clarity, those formats, as performed by the process path 10.about., are listed below.
______________________________________Format AStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (18 minutes) 4-17Container 15 passes through 18-21bypass region, first incubationcontinuesFirst incubation continues 22-40Container 15 passes through 41-44bypass region, first incubationcontinuesFirst incubation continues 45-17'Separation and wash 18'-21'Second reagent introduction and 25'-26'mixingSecond incubation (4 minutes) 27'-40'Separation and wash 41'-44'Container 15 transferred from 46' of 28process lane 28 to process lane to 46 of170 170Pretrigger introduction and 48mixingThird incubation (1 minute) 49-51Trigger and read 52Container 15 evacuate 54Container 15 removal 55______________________________________
As an example, Format A may be used to determine at least the following items of interest: antibodies to HCV, antibodies to HIV 1/HIV 2, antibodies to hepatitis B core antigen (HBcAb), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), Hepatitis B Surface Antigen (HBsAg) antibodies to Hepatitis B Surface antigen (HBsAb), alpha-fetoprotein (AFP), Total prostate specific antigen (Total PSA), Free PSA, Thyroid stimulating Hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), beta human chorionic gonadotropin (B-hCG), Free Thyroxine (Free T4), Free triiodothyronine (Free T3), Total T4, Total T3, Prolactin and Ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format. For instance, this format may also be used to determine beta human chorionic gonadotropin (B-hCG), prolactin and ferritin.
______________________________________Format BStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (11 minutes) 4-40Separation and wash 41-44Second reagent introduction and 2'-3'mixingSecond incubation (11 minutes) 4'-40'Separation and wash 41'-44'Container 15 transferred from 46' of 28process lane 28 to process lane to 46 of170 170Pretrigger introduction and 48mixingThird incubation (1 minute) 49-51Trigger and read 52Container 15 evacuate 54Container 15 removal 55______________________________________
As an example, Format B may be used to determine an item of interest in a sample where a relatively increased degree of sensitivity, as compared with some other formats, is desired. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.
______________________________________Format CStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (11 minutes) 4-40Separation and wash 41-44Second reagent introduction and 2'-3'mixingSecond incubation (4 minutes) 4'-17'Separation and wash 18'-21'Third reagent introduction and 25'-26'mixingThird incubation (4 minutes) 27'-40'Separation and wash 41'-44'Container 15 transferred from 46' of 28process lane 28 to process lane to 46 of170 170Pretrigger introduction and 48mixingFourth incubation (1 minute) 49-51Trigger and read 52Container 15 evacuate 54Container 15 removal 55______________________________________
As an example, Format C may be used when the item of interest relates to hepatitis, such as determinations for anti-M, HBcAb-M and HAVAb-M.
______________________________________Step Position______________________________________Format DSample introduction 1First reagent introduction and 2-3mixingFirst incubation (6 minutes) 4-17Transfer to second container 15 24in position 1Second reagent introduction and 2-3mixingSecond incubation (11 minutes) 4-40Separation and wash 41-44Third reagent introduction and 2'-3'mixingThird incubation (4 minutes) 4'-17'Separation and wash 18'-21'Fourth reagent introduction and 24'-25'MixingFourth incubation (4 minutes) 27'-40'Separation and wash 41'-44'Container transferred from 46' of 28process lane 28 to process lane to 46 of170 170Pretrigger introduction and 48mixingFifth incubation (1 minute) 49-51Trigger and read 52Container 15 evacuate 54Container 15 removal 55Format ESample introduction 1First reagent 2-3introduction and mixingFirst incubation (7 4-23minutes)Transfer portion of 24container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 25-17'contents continues firstincubation (11 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 passes 18'-21'through bypass region 58 BSecond container 15 first 4-17'incubation (18 minutes)Introduction of fourth 24'-25 'reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 18'-21'separation and washFourth incubation (4 26-40'minutes-optional) offirst container 15Third reagent 24'-25'introduction into secondcontainer 15 and mixingFirst container 15 passes 41'-44'through bypass regionThird incubation (4 26-40'minutes) of secondcontainer 15First container 15 46' of 28 to 46 of 170transferred from processlane 28 to process lane170Pretrigger introduction 48into first container 15and mixingSeparation and wash of 41'-44'second container 15Second container 15 46' of 28 to 46 of 170transferred from processlane 28 to process lane170Trigger and read value 1 52(Total Hb) from firstcontainer 15Pretrigger introduction 48into second container 15and mixingTrigger and read value 2 52(GlyHb)Reported result = value 2 .times. 100 value 1______________________________________
For example, in Format E, it is possible to modify the format by disregarding the first container 15 after the portion of the container 15 contents has been transferred (Position 24) to the second container 15. In that case, Format E may be used to determine, for example, folate and vitamin B12.
______________________________________Format FStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation (6 4-23minutes)Transfer portion of 24container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 25-17'contents continues firstincubation (11 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 passes 18'-21'through bypass region 58 BSecond container 15 first 4-40incubation (11 minutes)Introduction of fourth 24'-25'reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 41-44separation and washFourth incubation (4 26-40'minutes-optional) offirst container 15Third reagent 2'-3'introduction into secondcontainer 15 and mixingFirst container 15 passes 41'-44'through bypass regionThird incubation (11 4'-40'minutes) of secondcontainer 15First container 15 46' of 28 to 46 of 170transferred from processlane 28 to process lane170Pretrigger introduction 48into first container 15and mixingSeparation and wash of 41'-44'second container 15Trigger and read value 1 52(Total Hb) from firstcontainer 15Second container 15 46' of 28 to 46 of 170transferred from processlane 28 to process lane170Pretrigger introduction 48into second container 15and mixingTrigger and read value 2 52(GlyHb)Reported result = value 2 .times. 100 value 1______________________________________
This format may be used, for example, to determine at least one of total and glycated hemoglobin. Also, this format may be modified by disregarding the first container 15 as in Format E.
______________________________________Format GStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation (6 4-23minutes)Transfer portion of 25container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 25-17'contents continues firstincubation (12 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 18'-21'separation and washSecond container 15 first 4-17'incubation (18 minutes)Introduction of fourth 24"-25'reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 18'-21'separation and washFourth incubation (4 27'-40'minutes-optional) offirst container 15Third reagent 24-26'introduction into secondcontainer 15 and mixingFirst container 15 41'-44'separation and washThird incubation (4 26-40'minutes) of secondcontainer 15First container 15 46' of 28 to 46 of 170transferred from processlane 28 to process lane170Pretrigger introduction 48into first container 15and mixingSeparation and wash of 41'-44'second container 15Second container 15 46' of 28 to 46 of 170transferred from processlane 28 to process lane170Trigger and read value 1 52(Total Hb) from firstcontainer 15Pretrigger introduction 48into second container 15and mixingTrigger and read value 2 52(GlyHb)Reported result = value 2 .times. 100 value 1______________________________________
As an example, this format may also be modified as may be done with Format F. With that modification, this Format may be used to determine progesterone, testosterone and estradiol.
______________________________________Format HStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation 4-41'Separation and wash 42'-44'Container 15 transfer 46' of 28 to 46 of 170from process lane 28 toprocess lane 170Pretrigger introduction 48and mixingSecond incubation 49-51Trigger and read 52______________________________________
As an example, this format may be used to determine, among other things, beta human chorionic gonadotropin (B-hCG), prolactin, progesterone, testosterone, estradiol and ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.
______________________________________Format IStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2introduction into firstcontainer 15, portion offirst container 15contents moved intopipettor, remainder ofcontainer continues onprocess lane 28,bypassing all washstations, to Position 25'First reagent 2-3introduction into secondcontainer 15 and mixingSecond container 15 first 4-17'incubation (18 minutes)Introduction of second 25'-26'reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 18'-21'separation and washFourth incubation (4 27'-40'minutes-optional) offirst container 15Third reagent 25'-26'introduction into secondcontainer 15 and mixingFirst container 15 passes 41'-44'through bypass region 58Third incubation (4 27'-40'minutes) of secondcontainer 15Pretrigger introduction 48into first container 15and mixingSeparation and wash of 41'-44'second container 15Trigger and read value 1 52(Total Hb) from firstcontainer 15Pretrigger introduction 48into second container 15and mixingTrigger and read value 2 52(GlyHb)Reported result = value 2 .times. 100 value 1______________________________________
As an example, in Format I, it is possible to modify the format by disregarding the first container 15 after the portion of the container 15 contents has been transferred (Position 24) to the second container 15. In that case, Format I may be used to determine, for example, folate and vitamin B12.
______________________________________Format JStep Position______________________________________Sample introduction into 1container 15, possiblywith diluent fluidFirst reagent 2-3introduction and mixingFirst incubation (27 4-47minutes-two times alongprocess lane 28)Pretrigger introduction 48and mixingSecond incubation (1 49-51minute)Trigger and read 52______________________________________
As an example, Format J may be used to determine, among other things, total hemoglobin.
The embodiments described herein also allow for sample pretreatment which may be performed in at least two ways, indicated as Formats K and L. During performance of sample pretreatment, fluid present in the containers 15 indicated may be processed, after they are no longer significant in the pretreatment steps, in any appropriate manner, such as any of the Formats discussed above. Also, as will become clear later on, both Formats K and L are substantially similarly applicable to the other embodiment of the process path 10 discussed below.
______________________________________Format KStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2-3introduction and mixingFirst incubation (6 4-23minutes)Transfer portion of 24contents of firstcontainer 15 to secondcontainer 15 in PositionSecond reagent 2-3introduction to secondcontainer 15 and mixing(optional)Transfer portion of 24contents of secondcontainer 15 to thirdcontainer 15 in Position1Third reagent 2-3introduction to thirdcontainer and mixing(optional)______________________________________
As an example, the third container 15 may be processed according to at least one of Formats A (to determine, among other things, folate), B, C, H and J.
______________________________________Format LStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2-3introduction and mixingFirst incubation (7 4-23minutes)Transfer portion of 24contents of firstcontainer 15 to secondcontainer 15 in PositionSecond reagent 2-3introduction to secondcontainer 15 and mixing(optional)______________________________________
As an example, the second container 15 may be processed according to at least one of Formats A (to determine, among other things, folate, vitamin B12, confirm HBsAg), B, C, H and J.
Another embodiment is a process path 10*, substantially similar to the previous embodiment, of the process path 10 is constructed to perform 50 determinations per hour. Elements similar to those described earlier, along with the same index period and assay formats are used, thereby allowing use of the same reagents albeit in an embodiment having relatively smaller physical dimensions. Following the examples discussed above, the following examples relate to this process path 10*. In these examples, it is assumed that only one pipettor is utilized. Also, whereas the previous examples performed determinations while moving a container 15 along the process lane 28 twice, the process path 10* performs determinations while moving a container 15 along the process lane 28 four times. Thus, the second time Process Position 1 is encounter is indicated as 1', the third time as 1" and the four time as '". However, it is to be noted that more or less movements along the process lane 28 may be employed. Also, the process lane 28 of this embodiment includes 23 Process Positions with Process Position 23 being located adjacent to Process Position 1.
______________________________________ProcessPosition Process Step Description______________________________________1 Container 15 load Container 15 moved from loading lane 30, if present, to process lane 28 as required1 Pipettor Sample deposited into container 15 by pipetting system2 Pipettor Reagent obtained from reagent carousel 131 deposited into container 153 Mixer Contents of container 15 are mixed by a device 86 imparting motion to the container 154-16 Incubation Contents of container 15 are incubated at a controlled temperature, about 37 degrees Celsius17 Bypass region start Container 15 is selectively positioned at entry to performance lane 62 or avoidance lane 64 of bypass region18 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation and fluid addition19 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition20 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation, container 15 contents aspiration and fluid addition21 Wash zone 1 Container 15 in performance lane 62 undergoes magnetic separation, and container 15 contents aspiration22 Bypass region end Performance and avoidance lanes 62 and 64 of bypass region merge23 Process lane Container 15 selectively transfer transferred from process lane 23 to process lane 17024 Pre-Trigger and Reagent added to container 15 and Mixer mechanically mixed26-28 Incubation Contents of container 15 are incubated at controlled temperature29 Shutter, reader, Indicator reaction (such as and trigger chemiluminescent reaction) triggered and read with magnetic particles pulled out of solution with magnet. Shutter blocks light.30-31 Liquid Waste Magnetic particles are held at a Aspirate wall of the container 15 and all liquid in container 15 is aspirated and discarded32 Container 15 unload Container 15 removed from process lane 28______________________________________
Given these modifications, it is possible to utilize determination formats that are substantially similar to those discussed previously. For the sake of clarity, those formats, as performed by a process path that performs 50 determinations per hour, are listed below.
______________________________________Format AStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (18 minutes) 4-17Container 15 passes through 18-21bypass region, first incubationcontinuesFirst incubation continues 22-17"Separation and wash 18"-21"Second reagent introduction and 2'"-3'"mixingSecond incubation (4 minutes) 4'"-17'"Separation and wash 18'"-21'"Container 15 transferred from 23'" of 28process lane 28 to process lane to 23 of170 170Pretrigger introduction and 24mixingThird incubation (1 minute) 25-28Trigger and read 29Container 15 evacuate 31Container 15 removal 32______________________________________
As an example, Format A may be used to determine at least the following items of interest: antibodies to HCV, antibodies to HIV1/HIV2, antibodies to hepatitis B core antigen (HBcAb), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), Hepatitis B Surface Antigen (HBsAg), antibodies to Hepatitis B Surface antigen (HBsAb), alpha-fetoprotein (AFP), Total prostate specific antigen (Total PSA), Free PSA, Thyroid stimulating Hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), beta human chorionic gonadotropin (B-hCG), Free Thyroxine (Free T4), Free triiodothyronine (Free T3), Total T4, Total T3, Prolactin and Ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format. For instance, this format may also be used to determine beta human chorionic gonadotropin (B-hCG), prolactin and ferritin.
______________________________________Format BStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (14 minutes) 4-17'Separation and wash 18'-21'Second reagent introduction and 2"-3"mixingSecond incubation (14 minutes) 4"-17'"Separation and wash 18'"-21'"Container 15 transferred from 23'" of 28process lane 28 to process lane to 23 of170 170Pretrigger introduction and 25mixingThird incubation (1 minute) 26-28Trigger and read 29Container 15 evacuate 31Container 15 removal 32______________________________________
As an example, Format B may be used to determine an item of interest in a sample where a relatively increased degree of sensitivity, as compared with some other formats, is desired. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.
______________________________________Format CStep Position______________________________________Sample introduction 1First reagent introduction and 2-3mixingFirst incubation (11 minutes) 4-17'Separation and wash 18'-21'Second reagent introduction and 2"-3"mixingSecond incubation (4 minutes) 4"-17"Separation and wash 18"-21"Third reagent introduction and 2'"-3'"mixingThird incubation (4 minutes) 4'"-17'"Separation and wash 18'"-21'"Container 15 transferred from 23'" of 28process lane 28 to process lane to 23 of170 170Pretrigger introduction and 25mixingFourth incubation (1 minute) 26-28Trigger and read 29Container 15 evacuate 31Container 15 removal 32______________________________________
As an example, Format C may be used when the item of interest relates to hepatitis, such as determinations for anti-M, HBcAb-M and HAVAb-M.
______________________________________Step Position______________________________________Format DSample introduction 1First reagent introduction and 2-3mixingFirst incubation (4 minutes) 4-17Transfer to second container 15 24in position 1Second reagent introduction and 2-3mixingSecond incubation (14 minutes) 4-17'Separation and wash 18'-21'Third reagent introduction and 2"-3"mixingThird incubation (4 minutes) 4"-17"Separation and wash 18"-21"Fourth reagent introduction and 2'"-3'"mixingFourth incubation (4 minutes) 4'"-17'"Separation and wash 18'"-21'"Container transferred from 23'" of 28process lane 28 to process lane to 23 of170 170Pretrigger introduction and 25mixingFifth incubation (1 minute) 26-28Trigger and read 29Container 15 evacuate 31Container 15 removal 32Format ESample introduction 1First reagent 2-3introduction and mixingFirst incubation (7 4-17minutes)Transfer portion of 24container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 24-17'contents continues firstincubation (11 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 passes 18"-21"through bypass region 58BSecond container 15 first 4-17"incubation (18 minutes)Introduction of fourth 2'"-3'"reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 18'-21'separation and washFourth incubation (4 4'"-17'"minutes - optional) offirst container 15Third reagent 24'-25'introduction into secondcontainer 15 and mixingFirst container 15 passes 18'"-21'"through bypass regionThird incubation (4 4'"-17'"minutes) of secondcontainer 15First container 15 23'" of 28 to 23 of 170transferred from processlane 28 to process lane170Pretrigger introduction 25into first container 15and mixingSeparation and wash of 18'"-21'"second container 15Second container 15 23'" of 28 to 23 of 170transferred from processlane 28 to process lane170Trigger and read value 1 29(Total Hb) from firstcontainer 15Pretrigger introduction 25into second container 15and mixingTrigger and read value 2 29(GlyHb)______________________________________ ##STR5##- For example, in Format E, it is possible to modify the format by disregarding the first container 15 after the portion of the container 15 contents has been transferred (Position 24) to the second container 15. In that case, Format E may be used to determine, for example, folate and vitamin B12.
______________________________________Format FStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation (7 4-17minutes)Transfer portion of 23container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 23-17"contents continues firstincubation (11 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 passes 18"-21"through bypass region 58BSecond container 15 first 4-17'incubation (11 minutes)Introduction of fourth 2'"-3'"reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 18'-21'separation and washFourth incubation (4 4'"-17'"minutes - optional) offirst container 15Third reagent 2'"-3'"introduction into secondcontainer 15 and mixingFirst container 15 passes 18'"-21'"through bypass regionThird incubation (11 4'"-17'"minutes) of secondcontainer 15First container 15 23'" of 28 to 23 of 170transferred from processlane 28 to process lane170Pretrigger introduction 25into first container 15and mixingSeparation and wash of 18'"-21'"second container 15Trigger and read value 1 29(Total Hb) from firstcontainer 15Second container 15 23'" of 28 to 23 of 170transferred from processlane 28 to process lane170Pretrigger introduction 25into second container 15and mixingTrigger and read value 2 29(GlyHb)______________________________________ ##STR6##- This format may be used, for example, to determine at least one of tota and glycated hemoglobin. Also, this format may be modified by disregarding the first container 15 as in Format E.
______________________________________Format GStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation (6 4-23minutes)Transfer portion of 23container 15 contents tosecond container 15,remainder of container 15continues on process lane28First container 15 24-17"contents continues firstincubation (12 minutes)Second reagent 2-3introduction and mixingwith second container 15contentsFirst container 15 18"-21"separation and washSecond container 15 first 4-17"incubation (18 minutes)Introduction of fourth 2'"-3'"reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 18"-21"separation and washFourth incubation (4 4'"-17'"minutes - optional) offirst container 15Third reagent 2'"-3'"introduction into secondcontainer 15 and mixingFirst container 15 18'"-21'"separation and washThird incubation (4 4'"-17'"minutes) of secondcontainer 15First container 15 23'" of 28 to 23 of 170transferred from processlane 28 to process lane170Pretrigger introduction 25into first container 15and mixingSeparation and wash of 18'"-21'"second container 15Second container 15 23'" of 28 to 23'" of 170transferred from processlane 28 to process lane170Trigger and read value 1 29(Total Hb) from firstcontainer 15Pretrigger introduction 25into second container 15and mixingTrigger and read value 2 29(GlyHb)______________________________________ ##STR7##- As an example, this format may also be modified as may be done with Format F. With that modification, this Format may be used to determine progesterone, testosterone and estradiol.
______________________________________Format HStep Position______________________________________Sample introduction 1First reagent 2-3introduction and mixingFirst incubation 4-17'"Separation and wash 18'"-21'"Container 15 transfer 23'" of 28 to 23 of 170from process lane 28 toprocess lane 170Pretrigger introduction 25and mixingSecond incubation 26-28Trigger and read 29______________________________________
As an example, this format may be used to determine, among other things, beta human chorionic gonadotropin (B-hCG), prolactin, progesterone, testosterone, estradiol and ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.
______________________________________Format IStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2introduction into firstcontainer 15, portion offirst container 15contents moved intopipettor, remainder ofcontainer continues onprocess lane 28,bypassing all washstations, to Position 25'First reagent 2-3introduction into secondcontainer 15 and mixingSecond container 15 first .sup. 4-17"incubation (18 minutes)Introduction of second 2'"-3'"reagent into firstcontainer 15 and mixing(optional, enhances totalHb chemiluminescentsignal)Second container 18'"-21'"separation and washFourth incubation (4 4'"-17'"minutes - optional) offirst container 15Third reagent 2'"-3'"introduction into secondcontainer 15 and mixingFirst container 15 passes 18'"-21'"through bypass region 58Third incubation (4 4'"-17'"minutes) of secondcontainer 15Pretrigger introduction 25into first container 15and mixingSeparation and wash of 18'"-21'"second container 15Trigger and read value 1 29(Total Hb) from firstcontainer 15Pretrigger introduction 25into second container 15and mixingTrigger and read value 2 29(GlyHb)______________________________________ ##STR8##- As an example, in Format I, it is possible to modify the format by disregarding the first container 15 after the portion of the container 15 contents has been transferred (Position 24) to the second container 15. In that case, Format I may be used to determine, for example, folate and vitamin B12.
______________________________________Format JStep Position______________________________________Sample introduction into 1container 15, possiblywith diluent fluidFirst reagent 2-3introduction and mixingFirst incubation (27 4-47'"minutes - four timesalong process lane 28)Pretrigger introduction 25and mixingSecond incubation (1 26-28minute)Trigger and read 29______________________________________
As an example, Format J may be used to determine, among other things, total hemoglobin.
The embodiments described herein also allow for sample pretreatment which may be performed in at least two ways, indicated as Formats K and L. During performance of sample pretreatment, fluid present in the containers 15 indicated may be processed, after they are no longer significant in the pretreatment steps, in any appropriate manner, such as any of the Formats discussed above. Also, as will become clear later on, both Formats K and L are substantially similarly applicable to the other embodiment of the process path 10 discussed below.
______________________________________Format KStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2-3introduction and mixingFirst incubation (6 4-23minutes)Transfer portion of 24contents of firstcontainer 15 to secondcontainer 15 in Position 1Second reagent 2-3introduction to secondcontainer 15 and mixing(optional)Transfer portion of 24contents of secondcontainer 15 to thirdcontainer 15 in Position 1Third reagent 2-3introduction to thirdcontainer and mixing(optional)______________________________________
As an example, the third container 15 may be processed according to at least one of Formats A (to determine, among other things, folate), B, C, H and J.
______________________________________Format LStep Position______________________________________Sample introduction into 1first container 15,possibly with diluentfluidFirst reagent 2-3introduction and mixingFirst incubation (7 4-23minutes)Transfer portion of 24contents of firstcontainer 15 to secondcontainer 15 in Position 1Second reagent 2-3introduction to secondcontainer 15 and mixing(optional)______________________________________
As an example, the second container 15 may be processed according to at least one of Formats A (to determine, among other things, folate, vitamin B12, confirm HBsAg), B, C, H and J.
Given commonality among the various embodiments of the process path discussed and exemplified above, it is to be appreciated that assay formats performed on each of the various embodiments are essentially the same. The time frames are identical. Reagents for a particular assay used on one of the embodiments may also be used on other embodiments.
Upon consideration of all of these examples and their common features, it is to be understood that the process path 10, or in other words the process lane 28, has a variable physical length. However, the effective length of the process path 10 is constant in all embodiments. This effective length represents the total distance traveled by the container 15 along the process path 10 during performance of a certain determination. The physical length, i.e. the physical dimensions of the process path 10, is variable, for instance, to make the process path 10 fit within a given space. The effective length of the process path 10 is maintained constant by moving the container 15 multiple times along the same process path 10 (4 times in the last set of examples). Maintenance of the effective length is achieved with appropriate combination of selective automatic performance of a given determination process step. In all instances, the effective length remains constant even though the physical length of a given process path 10 may be longer or shorter than other process paths 10.
It is to be noted that all of the above discussed embodiments of the process path 10 include and utilize certain common elements, such as reagents, a sample/reagent pipettor, a mixer, a wash zone and a reader. The structural elements are arranged along each embodiment of the process path 10 such that each embodiment is able to perform the same determinations in substantially the same manner by keeping the effective length of the process path 10 constant. Each of the embodiments of the process path executes determinations with approximately the same number, such as 98 in the above examples, "steps" of the container 15 along the process path 10 between sample introduction and reading. Determination of a given item of interest by one of the embodiments of the process path 10 takes substantially the same amount of time as a determination of the same item of interest by another embodiment of the process path 10. Thus, it is possible to construct a structure for performing item of interest determinations which conforms to desired physical dimensions, throughput requirements, etc., while using the common elements discussed herein by maintaining the effective length of the process path constant.

Claims

1. A method of constructing a process lane for determining an item of interest in a sample, the method comprising the steps of:
(a) accepting a container containing said sample in a process lane having a first physical length where a plurality of process steps for determining an item of interest in said sample are selectively automatically performed on said sample;
(b) selectively automatically performing said process steps on the sample in the container on said process lane having said first physical length;
(c) selectively varying a physical length of said process lane to form a second physical length which differs from said first physical length;
(d) accepting said container containing said sample in said process lane having said second physical length;
(e) selectively automatically performing said process steps on said sample in said container on said process lane having said second physical length; and
(f) maintaining an effective length of said process lane on both first and second physical lengths constant wherein said effective length representing a total traveled distance of said container on said process lane,
wherein said process steps performed on said sample on said first physical length and second physical length being substantially the same by maintaining said effective length of said process lane constant.
2. A method as defined in claim 1 further comprising the step of:
(d) moving the container along the first physical length of the process lane at least once.
3. A method as defined in claim 1 further comprising the step of:
(d) moving the container along the second physical length of the process lane at least twice.

US Referenced Citations (784)

Number	Name	Date
RE29169	Schuurs et al.	Apr 1977
RE29880	Duff	Jan 1979
RE30627	Bagshawe et al.	May 1981
RE30730	Duff	Sep 1981
D278182	Aihara et al.	Mar 1985
D283728	Aihara	May 1986
D288845	Borer et al.	Mar 1987
D309080	Buchholz	Jul 1990
D330428	Lewis et al.	Oct 1992
D344138	Nagata	Feb 1994
D347479	Hansen et al.	May 1994
D358660	Swift	May 1995
D359361	Swift	Jun 1995
544767	Lewis et al.	Sep 1895
893469	Essmuller	Jul 1908
1180665	McElroy	Apr 1916
2587221	Richardson et al.	Feb 1952
2837092	Scholler et al.	Jun 1958
2906423	Sandhage	Sep 1959
2948940	Degener	Aug 1960
2955722	Antonious	Oct 1960
3019932	Singiser	Feb 1962
3038340	Isreeli	Jun 1962
3085705	Varney	Apr 1963
3107537	Isreeli et al.	Oct 1963
3178266	Anthon	Apr 1965
3190731	Weiskoff	Jun 1965
3192968	Baruch et al.	Jul 1965
3193358	Baruch	Jul 1965
3223269	Williams	Dec 1965
3272240	Roth	Sep 1966
3302772	Alsop	Feb 1967
3307371	Andros	Mar 1967
3317069	Chin	May 1967
3399116	Du Bois et al.	Aug 1968
3457048	Stephens et al.	Jul 1969
3489521	Buckle et al.	Jan 1970
3489525	Natelson	Jan 1970
3533744	Unger	Oct 1970
3555143	Axen et al.	Jan 1971
3578291	Oberil	May 1971
3594129	Jones	Jul 1971
3606074	Hayes	Sep 1971
3607094	Beer	Sep 1971
3607098	Strande	Sep 1971
3609040	Kuzel et al.	Sep 1971
3615230	Barnick et al.	Oct 1971
3616264	Ray et al.	Oct 1971
3617222	Matte	Nov 1971
3621203	Geominy et al.	Nov 1971
3633768	Gulgen	Jan 1972
3634651	Siegel	Jan 1972
3635094	Oberli	Jan 1972
3638507	Orner	Feb 1972
3643812	Mander et al.	Feb 1972
3644095	Netheler et al.	Feb 1972
3652761	Woetail	Mar 1972
3653528	Wimmer	Apr 1972
3654090	Wihelmus	Apr 1972
3655089	Tower	Apr 1972
3658478	Spergel et al.	Apr 1972
3673886	Tomita et al.	Jul 1972
3676080	Richterich	Jul 1972
3676679	Waters	Jul 1972
3687632	Natelson	Aug 1972
3702612	Schlesinger	Nov 1972
3708264	Jottier	Jan 1973
3720116	Better et al.	Mar 1973
3722312	Better et al.	Mar 1973
3723066	Moran	Mar 1973
3727029	Chrow	Apr 1973
3728079	Moran	Apr 1973
3746514	Colvin et al.	Jul 1973
3753657	Downing et al.	Aug 1973
3764268	Kosowsky et al.	Oct 1973
3765237	Blackmer et al.	Oct 1973
3767364	Ritchie et al.	Oct 1973
3770382	Carter et al.	Nov 1973
3784785	Noland	Jan 1974
3790346	Ritchie	Feb 1974
3791537	Conklin	Feb 1974
3796544	Zauft et al.	Mar 1974
3806321	Durrum et al.	Apr 1974
3807457	Logsdon	Apr 1974
3807955	Note, Jr. et al.	Apr 1974
3811842	Diebler et al.	May 1974
3813215	Ward	May 1974
3823840	Zackheim	Jul 1974
3826397	Atkins	Jul 1974
3826621	Johnson, Jr. et al.	Jul 1974
3830108	Spong	Aug 1974
3843323	Quame	Oct 1974
3850174	Ayres	Nov 1974
3850341	Bart	Nov 1974
3850580	Moore et al.	Nov 1974
3851541	Ploss et al.	Dec 1974
3854879	Figueroa et al.	Dec 1974
3868493	Caroleo	Feb 1975
3883305	Hoskins et al.	May 1975
3883306	Widen	May 1975
3894706	Mizusawa	Jul 1975
3897216	Jones	Jul 1975
3900289	Liston	Aug 1975
3912456	Young	Oct 1975
3917455	Bak et al.	Nov 1975
3933997	Hersh et al.	Jan 1976
3948607	Atwood et al.	Apr 1976
3949189	Bibro et al.	Apr 1976
3951605	Natelson	Apr 1976
3970518	Giaever	Jul 1976
3977551	Ciarico	Aug 1976
3980268	Ellis	Sep 1976
3981776	Saxholm	Sep 1976
3985508	Williams	Oct 1976
4000252	Kosak	Dec 1976
4000973	Petesen	Jan 1977
4000974	Acord	Jan 1977
4002532	Weltman et al.	Jan 1977
4004883	Meyer et al.	Jan 1977
4016043	Schuurs et al.	Apr 1977
4018886	Giaever	Apr 1977
4022579	Revillet et al.	May 1977
4034071	Strickler	Jul 1977
4039287	Moran	Aug 1977
4039652	Adams et al.	Aug 1977
4040533	De Boer et al.	Aug 1977
4041146	Giaever	Aug 1977
4045179	Bunce	Aug 1977
4046248	Goffredo et al.	Sep 1977
4047034	Auphan	Sep 1977
4054416	Duff	Oct 1977
4058367	Gilford	Nov 1977
4065358	Kawai et al.	Dec 1977
4066412	Johnson et al.	Jan 1978
4067694	Blakely et al.	Jan 1978
4077444	Gilson et al.	Mar 1978
4077804	Vanzo	Mar 1978
4078971	Arkles et al.	Mar 1978
4080833	Huber	Mar 1978
4081245	Polito	Mar 1978
4081246	Polito et al.	Mar 1978
4094641	Friswell	Jun 1978
4098876	Plasie et al.	Jul 1978
4104029	Maier, Jr.	Aug 1978
4106907	Charlton et al.	Aug 1978
4108972	Dreyer	Aug 1978
4112517	Giombini	Sep 1978
4118280	Charles et al.	Oct 1978
4118801	Kraft et al.	Oct 1978
4119709	Holub	Oct 1978
4120662	Fosslien	Oct 1978
4123121	Ernst et al.	Oct 1978
4125492	Cuatrecasas et al.	Nov 1978
4131788	Fulbrook	Dec 1978
4133383	Burns et al.	Jan 1979
4133436	Werder et al.	Jan 1979
4133873	Noller	Jan 1979
4134512	Nugent	Jan 1979
4137216	Lemper et al.	Jan 1979
4139242	Ernst	Feb 1979
4139604	Gutcho et al.	Feb 1979
4140020	Cook	Feb 1979
4141524	Corvese, Jr.	Feb 1979
4141687	Forrest et al.	Feb 1979
4147250	Schulz	Apr 1979
4151931	Scherer et al.	May 1979
4152210	Robinson et al.	May 1979
4152269	Babson	May 1979
4152577	Leavines	May 1979
4155534	Ithakissios	May 1979
4155535	Giaever	May 1979
4155861	Allington	May 1979
4155978	Naono et al.	May 1979
4157323	Yen et al.	Jun 1979
4160165	McCombs et al.	Jul 1979
4166095	Kling et al.	Aug 1979
4166104	Wagner et al.	Aug 1979
4168955	Allington	Sep 1979
4169138	Jonsson	Sep 1979
4169804	Yapel et al.	Oct 1979
4177253	Davies et al.	Dec 1979
4185084	Mochida et al.	Jan 1980
4187075	Noller	Feb 1980
4191287	Brook et al.	Mar 1980
4192845	Kalasek	Mar 1980
4193866	Slusarczuk et al.	Mar 1980
4200436	Mochida et al.	Apr 1980
4202634	Kraft et al.	May 1980
4205885	Ernst et al.	Jun 1980
4206094	Yen et al.	Jun 1980
4206951	Ernst et al.	Jun 1980
4207289	Weiss	Jun 1980
4208484	Sogi et al.	Jun 1980
4213999	Witiak et al.	Jul 1980
4218539	Weltman	Aug 1980
4228237	Hevey et al.	Oct 1980
4229104	Lahme et al.	Oct 1980
4230685	Senyei et al.	Oct 1980
4230797	Bogulaski et al.	Oct 1980
4231750	Dowben et al.	Nov 1980
4232119	Carlsson et al.	Nov 1980
4234538	Ginsberg et al.	Nov 1980
4234540	Ginsberg et al.	Nov 1980
4235869	Schwarzberg	Nov 1980
4235960	Sasse et al.	Nov 1980
4238195	Boguslaski et al.	Dec 1980
4239298	Ernst et al.	Dec 1980
4241176	Avrameas et al.	Dec 1980
4244459	Garrett	Jan 1981
4244920	Manschot et al.	Jan 1981
4250400	Lee	Feb 1981
4254460	Achter et al.	Mar 1981
4256106	Shoor	Mar 1981
4256725	Rutner et al.	Mar 1981
4256960	Snider	Mar 1981
4257884	Lim	Mar 1981
4259288	Welch	Mar 1981
4259289	Curry et al.	Mar 1981
4259291	Smythe	Mar 1981
4261893	Boguslaski et al.	Apr 1981
4265855	Mandle et al.	May 1981
4266651	Strom	May 1981
4267149	Bruckner et al.	May 1981
4267234	Rembaum	May 1981
4267235	Rembaum	May 1981
4268477	Herzstark	May 1981
4272482	Jessop et al.	Jun 1981
4272506	Schwarzberg	Jun 1981
4272510	Smith et al.	Jun 1981
4276051	Ginsberg et al.	Jun 1981
4276258	Ginsberg et al.	Jun 1981
4277440	Jessop et al.	Jul 1981
4278437	Haggar	Jul 1981
4279992	Boguslaski et al.	Jul 1981
4281387	Kraft et al.	Jul 1981
4292920	Smith et al.	Oct 1981
4294078	Percarpio et al.	Oct 1981
4294799	Stephens et al.	Oct 1981
4295572	Percarpio	Oct 1981
4297337	Mansfield et al.	Oct 1981
4298593	Ling	Nov 1981
4298687	Maes	Nov 1981
4302534	Halmann et al.	Nov 1981
4305668	Bilbrey	Dec 1981
4305924	Piasio et al.	Dec 1981
4307766	Tanokura	Dec 1981
4311348	Olschewski et al.	Jan 1982
4311667	Gocho	Jan 1982
4312835	Zoltan et al.	Jan 1982
4313734	Leuvering	Feb 1982
4313735	Yamashita et al.	Feb 1982
4315891	Sakurada	Feb 1982
4315907	Fridlender et al.	Feb 1982
4318707	Litman et al.	Mar 1982
4318884	Suzuki	Mar 1982
4318980	Boguslaski et al.	Mar 1982
4320109	Wolf et al.	Mar 1982
4322216	Lillig et al.	Mar 1982
4325909	Coulter et al.	Apr 1982
4325910	Jordan	Apr 1982
4330299	Cerami	May 1982
4332471	Gross	Jun 1982
4332783	Pernice et al.	Jun 1982
4333356	Bartels et al.	Jun 1982
4335620	Adams	Jun 1982
4335730	Griffin	Jun 1982
4341736	Drbal et al.	Jul 1982
4343766	Sisti et al.	Aug 1982
4343901	DeFilippi	Aug 1982
4345843	Berglund et al.	Aug 1982
4346056	Sakurada	Aug 1982
4346742	Chase et al.	Aug 1982
4349510	Kolehmainen et al.	Sep 1982
4351800	Kopp et al.	Sep 1982
4355165	Boguslaski et al.	Oct 1982
4356722	Bunce et al.	Nov 1982
4356967	Lunick	Nov 1982
4357301	Cassaday et al.	Nov 1982
4362531	de Steenwinkel et al.	Dec 1982
4363759	Boguslaski et al.	Dec 1982
4363781	Akamatsu et al.	Dec 1982
4366118	Bunce et al.	Dec 1982
4366119	Takeuchi	Dec 1982
4369226	Rembaum	Jan 1983
4372745	Mandle et al.	Feb 1983
4373925	Litman et al.	Feb 1983
4373931	Takekawa	Feb 1983
4376110	David et al.	Mar 1983
4380580	Boguslaski et al.	Apr 1983
4383031	Boguslaski et al.	May 1983
4385126	Chen et al.	May 1983
4397385	Booth et al.	Aug 1983
4402909	Solazzi	Sep 1983
4403040	Van Aken	Sep 1983
4407943	Cole et al.	Oct 1983
4407964	Elings et al.	Oct 1983
4414324	Stout	Nov 1983
4415700	Batz et al.	Nov 1983
4418846	Pong et al.	Dec 1983
4419734	Wolfson et al.	Dec 1983
4421860	Elings et al.	Dec 1983
4433059	Chang et al.	Feb 1984
4433060	Frenzel	Feb 1984
4435509	Berthold et al.	Mar 1984
4437762	Glenn et al.	Mar 1984
4438068	Forrest	Mar 1984
4438986	Teramachi	Mar 1984
4451433	Yamashita et al.	May 1984
4454226	Ali et al.	Jun 1984
4454234	Czerlinski	Jun 1984
4454939	Kampf et al.	Jun 1984
4455280	Shinohara et al.	Jun 1984
4456037	Gocho	Jun 1984
4459265	Berglund	Jul 1984
4459359	Neurath	Jul 1984
4472352	Quesneau et al.	Sep 1984
4477576	Deutsch et al.	Oct 1984
4477578	Miles et al.	Oct 1984
4478817	Campbell et al.	Oct 1984
4482636	Mochida et al.	Nov 1984
4483823	Umetsu et al.	Nov 1984
4483927	Takekawa	Nov 1984
4484061	Zelinka et al.	Nov 1984
4484815	Akiyama	Nov 1984
4488633	Kampf	Dec 1984
4491634	Frenzel	Jan 1985
4492751	Boguslaski et al.	Jan 1985
4495295	Neurath	Jan 1985
4495296	Neurath et al.	Jan 1985
4497774	Scordato	Feb 1985
4504585	Reynolds	Mar 1985
4506009	Lenhoff et al.	Mar 1985
4506777	Kampf	Mar 1985
4515752	Miramanda	May 1985
4517160	Galle et al.	May 1985
4517288	Giegel et al.	May 1985
4517460	Meulenbrugge et al.	May 1985
4517851	Tice	May 1985
4522921	Ogawa	Jun 1985
4523295	Zato	Jun 1985
4523862	Yasui et al.	Jun 1985
4523864	Walter et al.	Jun 1985
4528159	Liston	Jul 1985
4533255	Gronholz et al.	Aug 1985
4533629	Litman et al.	Aug 1985
4534465	Rothermel et al.	Aug 1985
4536369	Sakurada et al.	Aug 1985
4537510	Takahasi	Aug 1985
4537861	Elings et al.	Aug 1985
4540660	Harte et al.	Sep 1985
4541291	Churchill et al.	Sep 1985
4542661	Teramachi	Sep 1985
4542833	DeVaughn	Sep 1985
4545497	Martha, Jr.	Oct 1985
4551426	Freytag et al.	Nov 1985
4551619	Lefebvre	Nov 1985
4552812	Margel et al.	Nov 1985
4552839	Gould et al.	Nov 1985
4554088	Whitehead et al.	Nov 1985
4555183	Thomas	Nov 1985
4559120	Royse et al.	Dec 1985
4560269	Baldszun et al.	Dec 1985
4561820	Matheny, III et al.	Dec 1985
4576912	Yaverbaum et al.	Mar 1986
4578244	Cosgrove, Jr. et al.	Mar 1986
4581521	Grise	Apr 1986
4583668	Maynard, Jr.	Apr 1986
4584277	Ullman	Apr 1986
4588697	Khanna et al.	May 1986
4595562	Liston et al.	Jun 1986
4604348	Neurath	Aug 1986
4610546	Intraub	Sep 1986
4613567	Yasoshima et al.	Sep 1986
4615360	Jacobs	Oct 1986
4623621	Pestka	Nov 1986
4623629	Kerschensteiner	Nov 1986
4628037	Chagnon et al.	Dec 1986
4629688	Bolguslaski et al.	Dec 1986
4629690	Weng et al.	Dec 1986
4629703	Uffenheimer	Dec 1986
4634575	Kawakami et al.	Jan 1987
4634576	Galle et al.	Jan 1987
4637985	Sidki et al.	Jan 1987
4639135	Borer et al.	Jan 1987
4639425	Baier	Jan 1987
4639875	Abraham et al.	Jan 1987
4643879	Hanaway	Feb 1987
4645646	Gadow et al.	Feb 1987
4646747	Cais et al.	Mar 1987
4647432	Wakatake	Mar 1987
4649116	Daty et al.	Mar 1987
4651813	Witt et al.	Mar 1987
4652519	Warshawsky et al.	Mar 1987
4652533	Jolley	Mar 1987
4654299	Lentfer	Mar 1987
4654300	Zuk et al.	Mar 1987
4657851	Feller et al.	Apr 1987
4659678	Forrest et al.	Apr 1987
4661444	Li	Apr 1987
4661498	Lau et al.	Apr 1987
4663277	Wang	May 1987
4666866	Krauth	May 1987
4668617	Furuta et al.	May 1987
4670219	Nelson et al.	Jun 1987
4670381	Frickey et al.	Jun 1987
4670383	Baier et al.	Jun 1987
4672040	Josephson	Jun 1987
4676656	Cook et al.	Jun 1987
4676951	Armes et al.	Jun 1987
4678752	Thorne et al.	Jul 1987
4680275	Wagner et al.	Jul 1987
4681741	Hanaway	Jul 1987
4687638	Benajam	Aug 1987
4689305	Stiffey et al.	Aug 1987
4693969	Saxena et al.	Sep 1987
4693970	O'Connell et al.	Sep 1987
4695392	Whitehead et al.	Sep 1987
4695393	Whitehead et al.	Sep 1987
4698302	Whitehead et al.	Oct 1987
4699766	Yamashita	Oct 1987
4699767	Aihara	Oct 1987
4706736	Gyori	Nov 1987
4707251	Jenkins et al.	Nov 1987
4708886	Nelson	Nov 1987
4710472	Saur et al.	Dec 1987
4711839	Singhal	Dec 1987
4713974	Stone	Dec 1987
4731225	Wakatake	Mar 1988
4731337	Luotola et al.	Mar 1988
4732811	Margel	Mar 1988
4737342	Herrmann et al.	Apr 1988
4737453	Primus	Apr 1988
4738825	Kelln	Apr 1988
4740457	Parratt	Apr 1988
4743536	Evanega et al.	May 1988
4743544	Namba et al.	May 1988
4743560	Campbell et al.	May 1988
4745077	Holian et al.	May 1988
4747693	Kahl	May 1988
4753775	Ebersole et al.	Jun 1988
4754414	Gocho	Jun 1988
4755055	Johnson et al.	Jul 1988
4755356	Robbins et al.	Jul 1988
4758523	Harjunmaa	Jul 1988
4761268	Andersen et al.	Aug 1988
4761379	Williams et al.	Aug 1988
4763803	Schneider	Aug 1988
4764342	Kelln et al.	Aug 1988
4771429	Davis et al.	Sep 1988
4772453	Lisenbee	Sep 1988
4772550	Greenquist	Sep 1988
4774055	Wakatake et al.	Sep 1988
4774174	Giegel et al.	Sep 1988
4774191	Khanna et al.	Sep 1988
4775635	Ebersole et al.	Oct 1988
4775636	Moeremans et al.	Oct 1988
4777145	Luotola et al.	Oct 1988
4778763	Makiguchi et al.	Oct 1988
4778767	Hummelen et al.	Oct 1988
4780421	Kameda et al.	Oct 1988
4781891	Galle et al.	Nov 1988
4783336	Margel et al.	Nov 1988
4783835	Satoh	Nov 1988
4784213	Eager et al.	Nov 1988
4785953	Buchholz et al.	Nov 1988
4786606	Giegel et al.	Nov 1988
4788136	Grenier et al.	Nov 1988
4788150	Nelson et al.	Nov 1988
4791055	Boguslaski et al.	Dec 1988
4791056	Sizto et al.	Dec 1988
4793973	Ringrose	Dec 1988
4798095	Itoh	Jan 1989
4799599	Herrmann	Jan 1989
4806313	Ebersole et al.	Feb 1989
4808380	Minekane	Feb 1989
4808522	Atabekov et al.	Feb 1989
4816418	Mack et al.	Mar 1989
4820497	Howell	Apr 1989
4824778	Nagai et al.	Apr 1989
4827780	Sarrine et al.	May 1989
4830832	Arpagaus et al.	May 1989
4837159	Yamada	Jun 1989
4837395	Leeder et al.	Jun 1989
4842827	Graf et al.	Jun 1989
4843000	Litman et al.	Jun 1989
4843001	Haug et al.	Jun 1989
4843010	Nawinski et al.	Jun 1989
4845025	Lary et al.	Jul 1989
4848917	Benin et al.	Jul 1989
4849176	Sakagami	Jul 1989
4849338	Litman et al.	Jul 1989
4850470	Ferkany	Jul 1989
4852967	Cook et al.	Aug 1989
4855110	Marker et al.	Aug 1989
4855242	Soeldner	Aug 1989
4859423	Perlman	Aug 1989
4859583	Heller et al.	Aug 1989
4861553	Mawhirt et al.	Aug 1989
4861554	Sakuma	Aug 1989
4863690	Berthold et al.	Sep 1989
4863875	Bailey et al.	Sep 1989
4868130	Hargreaves	Sep 1989
4868131	Hiratsuka	Sep 1989
4871683	Harris et al.	Oct 1989
4886177	Foster	Dec 1989
4890930	Nohso	Jan 1990
4891311	Anawis et al.	Jan 1990
4895453	Devlin et al.	Jan 1990
4895650	Wang	Jan 1990
4900513	Barker et al.	Feb 1990
4900686	Arnost et al.	Feb 1990
4904583	Mapes et al.	Feb 1990
4904632	Pesek et al.	Feb 1990
4906432	Geiselman	Mar 1990
4906433	Minekane	Mar 1990
4908186	Sakamaki	Mar 1990
4910148	Sorensen et al.	Mar 1990
4911230	Maver et al.	Mar 1990
4916080	Imai et al.	Apr 1990
4916081	Kamada et al.	Apr 1990
4919887	Wakatake	Apr 1990
4927545	Roginski	May 1990
4927605	Dorn et al.	May 1990
4927769	Chang et al.	May 1990
4928539	Champecix	May 1990
4931385	Block et al.	Jun 1990
4931402	Abplanalp	Jun 1990
4933146	Meyer et al.	Jun 1990
4933276	Baret	Jun 1990
4935339	Zahradnik	Jun 1990
4937048	Sakai et al.	Jun 1990
4939946	Teramschi	Jul 1990
4941201	Davis	Jul 1990
4941809	Pinkerton	Jul 1990
4942017	Turpen	Jul 1990
4943164	Ohishi et al.	Jul 1990
4944924	Mawhirt et al.	Jul 1990
4946651	Liston et al.	Aug 1990
4948726	Longoria	Aug 1990
4950588	Dattagupta	Aug 1990
4951512	Mazza et al.	Aug 1990
4952707	Edwards et al.	Aug 1990
4953075	Nan et al.	Aug 1990
4954149	Fullemann	Sep 1990
4954319	Koizumi et al.	Sep 1990
4954452	Yost et al.	Sep 1990
4954882	Kamemoto	Sep 1990
4959303	Milburn et al.	Sep 1990
4961906	Andersen et al.	Oct 1990
4962023	Todd et al.	Oct 1990
4965049	Lillig et al.	Oct 1990
4965187	Tonelli	Oct 1990
4966839	Kaspar	Oct 1990
4967159	Manes	Oct 1990
4969565	Justai et al.	Nov 1990
4977786	Davis	Dec 1990
4978625	Wagner et al.	Dec 1990
4980293	Jeffs	Dec 1990
4984628	Uchida et al.	Jan 1991
4986891	Sarrine et al.	Jan 1991
4988618	Li et al.	Jan 1991
4989822	Fannon	Feb 1991
4992377	Saxholm	Feb 1991
4997768	Uffenheimer et al.	Mar 1991
5004582	Miyata et al.	Apr 1991
5004904	Yamakawa et al.	Apr 1991
5008082	Shaw	Apr 1991
5009942	Benin et al.	Apr 1991
5009998	Chow et al.	Apr 1991
5015157	Pinkerton et al.	May 1991
5017790	Kojima	May 1991
5020980	Pinkerton	Jun 1991
5024256	Vadher	Jun 1991
5030418	Miyata	Jul 1991
5037612	Takahashi et al.	Aug 1991
5038911	Doane et al.	Aug 1991
5038958	Dreier	Aug 1991
5039860	Yrionen et al.	Aug 1991
5043141	Wilson et al.	Aug 1991
5043143	Shaw et al.	Aug 1991
5044889	Pinkerton	Sep 1991
5047210	Melet	Sep 1991
5055262	Sakagami	Oct 1991
5057281	Torti et al.	Oct 1991
5061448	Mahe et al.	Oct 1991
5061630	Knopf et al.	Oct 1991
5066135	Meyer et al.	Nov 1991
5066844	Schuster et al.	Nov 1991
5068088	Hall et al.	Nov 1991
5071625	Kelln et al.	Dec 1991
5071766	Barr et al.	Dec 1991
5073625	Derbyshire	Dec 1991
5077013	Guigan	Dec 1991
5077488	Davis	Dec 1991
5079424	Kobayashi	Jan 1992
5081872	Greter	Jan 1992
5082628	Andreotti et al.	Jan 1992
5084242	Sakuma et al.	Jan 1992
5086215	Carsner et al.	Feb 1992
5086233	Stafford et al.	Feb 1992
5087423	Ishibashi	Feb 1992
5089418	Shaw et al.	Feb 1992
5091206	Wang et al.	Feb 1992
5096670	Harris et al.	Mar 1992
5098660	Devaney, Jr.	Mar 1992
5098661	Froehlich et al.	Mar 1992
5098663	Berthold et al.	Mar 1992
5102631	Jordan et al.	Apr 1992
5104231	Collier et al.	Apr 1992
5104621	Pfost et al.	Apr 1992
5104807	Mitsumaki et al.	Apr 1992
5104808	Laska et al.	Apr 1992
5108175	Whitlock	Apr 1992
5108703	Pfost et al.	Apr 1992
5108928	Menard et al.	Apr 1992
5112646	Koshi et al.	May 1992
5122343	Ishizaka et al.	Jun 1992
5123477	Tyler	Jun 1992
5127541	Wakatake	Jul 1992
5128103	Wang et al.	Jul 1992
5128105	Berthold et al.	Jul 1992
5130254	Collier et al.	Jul 1992
5133936	Umetsu et al.	Jul 1992
5137693	Mawhirt	Aug 1992
5139743	Ishizaka et al.	Aug 1992
5139744	Kowalski	Aug 1992
5139951	Butz et al.	Aug 1992
5143236	Gueret	Sep 1992
5145784	Cox et al.	Sep 1992
5147529	Lee et al.	Sep 1992
5158895	Ashihara et al.	Oct 1992
5162236	Pang et al.	Nov 1992
5163360	Petz	Nov 1992
5163582	Godolphin et al.	Nov 1992
5164318	Sato et al.	Nov 1992
5167929	Korf et al.	Dec 1992
5171979	Kwa et al.	Dec 1992
5174960	Shaw et al.	Dec 1992
5175086	Takekawa et al.	Dec 1992
5176203	Larzul	Jan 1993
5178019	Keiter	Jan 1993
5178479	Brown et al.	Jan 1993
5178834	Kagayama et al.	Jan 1993
5180555	Monget	Jan 1993
5183638	Wakatake	Feb 1993
5186339	Heissler	Feb 1993
5186827	Liberti et al.	Feb 1993
5187084	Hallsby	Feb 1993
5191967	Woltjer et al.	Mar 1993
5200084	Liberti et al.	Apr 1993
5200151	Long	Apr 1993
5200975	Kato	Apr 1993
5202093	Cloyd	Apr 1993
5206171	Dillon et al.	Apr 1993
5207986	Kadota et al.	May 1993
5208762	Charhut et al.	May 1993
5209903	Kanamori et al.	May 1993
5213761	Sakagami	May 1993
5215376	Schulte et al.	Jun 1993
5215714	Okada et al.	Jun 1993
5216926	Lipscomb	Jun 1993
5223218	Fukuoka et al.	Jun 1993
5225165	Perlman	Jul 1993
5229074	Heath et al.	Jul 1993
5232664	Krawzak et al.	Aug 1993
5232665	Burkovich	Aug 1993
5236666	Hulette	Aug 1993
5236824	Fujiwara et al.	Aug 1993
5238810	Fujiwara et al.	Aug 1993
5240674	Armor	Aug 1993
5240679	Stettler	Aug 1993
5242659	Wurschum	Sep 1993
5242660	Hsei	Sep 1993
5244633	Jakubowicz et al.	Sep 1993
5244663	Bruttmann et al.	Sep 1993
5246354	Pardinas	Sep 1993
5246665	Tyranski et al.	Sep 1993
5250440	Kelln et al.	Oct 1993
5252485	Zlobinsky et al.	Oct 1993
5254312	Staebler et al.	Oct 1993
5260028	Astle	Nov 1993
5264182	Sakagami	Nov 1993
5266272	Griner et al.	Nov 1993
5270210	Weyrauch et al.	Dec 1993
5272092	Hamasaki et al.	Dec 1993
5273715	Bridgham et al.	Dec 1993
5275299	Konrad et al.	Jan 1994
5277873	Hsei	Jan 1994
5279210	Pinkerton	Jan 1994
5282149	Grandone et al.	Jan 1994
5283079	Wang et al.	Feb 1994
5286652	James et al.	Feb 1994
5288466	Burns	Feb 1994
5290513	Berthold et al.	Mar 1994
5290708	Ashihara et al.	Mar 1994
5296191	Hall et al.	Mar 1994
5296195	Pang et al.	Mar 1994
5297599	Bucheli	Mar 1994
5298425	Kuhn et al.	Mar 1994
5304347	Mann et al.	Apr 1994
5304787	Wang	Apr 1994
5309981	Binder	May 1994
5312730	Piran et al.	May 1994
5314663	Mimura	May 1994
5314825	Weyrauch et al.	May 1994
5315094	Lisy	May 1994
5315375	Allen	May 1994
5316245	Ruckwardt	May 1994
5316726	Babson et al.	May 1994
5316954	Hupe et al.	May 1994
5318914	Matte et al.	Jun 1994
5320809	Dunn et al.	Jun 1994
5322668	Tomasso	Jun 1994
5324025	Chadwick et al.	Jun 1994
5324480	Shumate et al.	Jun 1994
5332679	Simons et al.	Jul 1994
5344610	Shaw	Sep 1994
5346303	Heinonen et al.	Sep 1994
5348705	Koreyasu et al.	Sep 1994
5350564	Mazza et al.	Sep 1994
5351801	Markin et al.	Oct 1994
5352612	Huber et al.	Oct 1994
5355304	DeMoranville et al.	Oct 1994
5363885	McConnell et al.	Nov 1994
5366062	Markin et al.	Nov 1994
5366697	Tomasso et al.	Nov 1994
5370843	Chiodo	Dec 1994
5371350	Motolese	Dec 1994
5372782	Karkantis et al.	Dec 1994
5374395	Robinson et al.	Dec 1994
5377854	Cusack	Jan 1995
5378433	Duckett et al.	Jan 1995
5378881	Adachi	Jan 1995
5380485	Takahashi et al.	Jan 1995
5380487	Choperena et al.	Jan 1995
5380488	Wakatake	Jan 1995
5384096	Burns	Jan 1995
5391499	Karkantis et al.	Feb 1995
5392949	McKenna	Feb 1995
5393965	Bravman et al.	Feb 1995
5399836	Pavlidis et al.	Mar 1995
5401465	Smethers et al.	Mar 1995
5414251	Durbin	May 1995
5415839	Zaun et al.	May 1995
5422075	Saito et al.	Jun 1995
5424036	Ushikubo	Jun 1995
5426976	McHardy et al.	Jun 1995
5427243	Roshdy	Jun 1995
5428470	Labriola, II	Jun 1995
5429330	Bond et al.	Jul 1995
5430957	Eigen et al.	Jul 1995
5433120	Boyd et al.	Jul 1995
5434051	Allard et al.	Jul 1995
5434083	Mitsumaki et al.	Jul 1995
5437361	Ohmori et al.	Aug 1995
5437838	DeMoranville et al.	Aug 1995
5437841	Balmer	Aug 1995
5439645	Saralegui et al.	Aug 1995
5439646	Tanimizu et al.	Aug 1995
5441895	Jakubowicz et al.	Aug 1995
5442164	Adachi	Aug 1995
5443790	Coeurveille et al.	Aug 1995
5443791	Cathcart et al.	Aug 1995
5445936	Piran et al.	Aug 1995
5445970	Rohr	Aug 1995
5445971	Rohr	Aug 1995
5453610	Gibbons	Sep 1995
5455175	Wittwer et al.	Oct 1995
5455414	Wang	Oct 1995
5456360	Griffin	Oct 1995
5457530	Nagai	Oct 1995
5458785	Howe et al.	Oct 1995
5458852	Buechler	Oct 1995
5462715	Koch et al.	Oct 1995
5468453	Holt et al.	Nov 1995
5469749	Shimada et al.	Nov 1995
5483843	Miller et al.	Jan 1996
5501841	Lee et al.	Mar 1996
5503036	Nguyen et al.	Apr 1996
5507193	Ishihara	Apr 1996
5519635	Miyake et al.	May 1996
5543112	Ghead et al.	Aug 1996
5623415	O'Bryan et al.	Apr 1997
B14906432	Geiselman	Jun 1991

Foreign Referenced Citations (176)

Number	Date	Country
2058175	Dec 1990	CAX
2083424	Nov 1992	CAX
0019871	May 1980	EPX
0019277	May 1980	EPX
0030087	Nov 1980	EPX
0038181	Apr 1981	EPX
0106536A2	Sep 1982	EPX
0078948	Oct 1982	EPX
0080108	Nov 1982	EPX
0080109	Nov 1982	EPX
0087786	Feb 1983	EPX
0097591	Jun 1983	EPX
0097591B1	Jun 1983	EPX
0097591A1	Jun 1983	EPX
0101192	Jul 1983	EPX
0100663	Jul 1983	EPX
0102661	Aug 1983	EPX
0106662	Oct 1983	EPX
0125995	May 1984	EPX
0144006B1	Nov 1984	EPX
0148166	Jan 1985	EPX
0149565A2	Jan 1985	EPX
0149565	Jan 1985	EPX
0149565B1	Jan 1985	EPX
0152964	Feb 1985	EPX
0152964A2	Feb 1985	EPX
0167834	Jun 1985	EPX
0169434A2	Jul 1985	EPX
0169434B1	Jul 1985	EPX
0169434	Jul 1985	EPX
0189280	Jan 1986	EPX
0198413	Apr 1986	EPX
0209290	Jul 1986	EPX
0219695	Sep 1986	EPX
0221308	Sep 1986	EPX
0239382B1	Mar 1987	EPX
0252631A2	Jun 1987	EPX
0253519B1	Jun 1987	EPX
0251087	Jun 1987	EPX
0252631B1	Jun 1987	EPX
0253519A2	Jun 1987	EPX
0273969B1	Jul 1987	EPX
0285654	Oct 1987	EPX
0285654B1	Oct 1987	EPX
0269752	Dec 1987	EPX
0281390	Mar 1988	EPX
0286119B1	Apr 1988	EPX
0549573A1	Jul 1988	EPX
0299659A2	Jul 1988	EPX
0314525	Oct 1988	EPX
0353264B1	Nov 1988	EPX
0346878B1	Jan 1989	EPX
0329183B1	Feb 1989	EPX
0329183A2	Feb 1989	EPX
0356883	Aug 1989	EPX
0355823A2	Aug 1989	EPX
0358948A2	Aug 1989	EPX
0355802B1	Aug 1989	EPX
0355801B1	Aug 1989	EPX
0356250B1	Aug 1989	EPX
0355823	Aug 1989	EPX
0396657B1	Sep 1989	EPX
0358948B1	Sep 1989	EPX
0371265B1	Oct 1989	EPX
0371265	Oct 1989	EPX
0658762A2	Feb 1990	EPX
0660115A2	Feb 1990	EPX
0409606	Jul 1990	EPX
0410645A3	Jul 1990	EPX
0410645A2	Jul 1990	EPX
0410645	Jul 1990	EPX
0409126A2	Jul 1990	EPX
0416285B1	Aug 1990	EPX
0417301A1	Sep 1990	EPX
0435481	Dec 1990	EPX
0435481A2	Dec 1990	EPX
0436995A2	Dec 1990	EPX
0438158B1	Jan 1991	EPX
0449321	Mar 1991	EPX
0452892A2	Apr 1991	EPX
0365569B1	May 1991	EPX
0467302A2	Jul 1991	EPX
0492499A2	Dec 1991	EPX
0502638	Feb 1992	EPX
0502638A2	Feb 1992	EPX
0512358A2	Apr 1992	EPX
0512368A3	Apr 1992	EPX
0523425	Jun 1992	EPX
0597017B1	Jul 1992	EPX
0596987B1	Jul 1992	EPX
0528708A1	Jul 1992	EPX
0544578A1	Nov 1992	EPX
0571716A1	Feb 1993	EPX
0572217A1	May 1993	EPX
0572185A2	May 1993	EPX
0572185A3	May 1993	EPX
0596205A2	Aug 1993	EPX
0616208A1	Mar 1994	EPX
0657382A2	Jul 1994	EPX
0637750A2	Jul 1994	EPX
0664501A1	Aug 1994	EPX
0638806A3	Aug 1994	EPX
0638806	Aug 1994	EPX
0643306A2	Sep 1994	EPX
0645631A2	Sep 1994	EPX
0653720A2	Nov 1994	EPX
0661535	Dec 1994	EPX
0670483A3	Feb 1995	EPX
0682258A1	Feb 1995	EPX
0672906A1	Mar 1995	EPX
0692308A2	Jul 1995	EPX
0712000A2	Sep 1995	EPX
0712000	Sep 1995	EPX
1573224	Jul 1969	FRX
2309869	Apr 1976	FRX
2523320	Mar 1983	FRX
2655426	Dec 1990	FRX
51272	Mar 1890	DEX
92212	Jun 1897	DEX
130053	Apr 1902	DEX
338227	Aug 1918	DEX
1428777	Mar 1973	DEX
2505268	Apr 1975	DEX
3244508	Jul 1984	DEX
3621831	Jan 1988	DEX
3926462A1	Feb 1991	DEX
1322728	May 1969	JPX
60-188849	Sep 1985	JPX
62-49070	Mar 1987	JPX
62-165057	Jul 1987	JPX
62-194464	Aug 1987	JPX
2-210266	Aug 1990	JPX
4047266	Feb 1992	JPX
123637	Aug 1964	GBX
1180957	Dec 1967	GBX
1473042	Nov 1977	GBX
1566098	Apr 1980	GBX
1592299	Jan 1981	GBX
1592297	Jan 1981	GBX
2202814	May 1988	GBX
2199407	Jul 1988	GBX
2228730	May 1990	GBX
2239093	Jun 1991	GBX
WO 8002280	Oct 1980	WOX
WO 8600139	Jul 1986	WOX
WO 8605518	Sep 1986	WOX
WO 8703966	Jul 1987	WOX
WO 8707727	Dec 1987	WOX
WO 8802866	Apr 1988	WOX
WO 8904373	May 1989	WOX
WO 9107662	Nov 1989	WOX
WO 9000252	Jan 1990	WOX
WO 9001168	Feb 1990	WOX
WO 9005903	May 1990	WOX
WO 9011511	Oct 1990	WOX
WO 9005411	May 1991	WOX
WO 9113335	Sep 1991	WOX
WO 9115768	Oct 1991	WOX
WO 9205448	Apr 1992	WOX
WO9212255	Jul 1992	WOX
WO 9216841	Oct 1992	WOX
WO 9216844	Oct 1992	WOX
WO 9220449	Nov 1992	WOX
WO 9222201	Dec 1992	WOX
WO 9301308	Jan 1993	WOX
WO 83.01308	Jan 1993	WOX
WO 9303383	Feb 1993	WOX
WO 9302364	Feb 1993	WOX
WO 9312430	Jun 1993	WOX
WO 9312431	Jun 1993	WOX
WO 9316801	Sep 1993	WOX
WO 9322686	Nov 1993	WOX
WO 9404929	Mar 1994	WOX
WO 9419451	Sep 1994	WOX
WO 9500829	Jan 1995	WOX
WO 9503548	Feb 1995	WOX

Non-Patent Literature Citations (84)

Entry
Luninescent Labels for Immunoassay From Concept to Practice; F. McCapra et al., Journal of Bioluminescence and Chemiliminescence vol. 4 51-58 1989.
J. Guesdon, et al Magnetic Solid Phase Enxyme Immunoassay; Immunochemistry 1977, vol. 14 443-447.
Yolken; Enzyme Immunoassays for the Detection of Infectious Antigens in Body Fluids: Current Limitations and Future Prospects; Reviews of Infectious Diseases vol. 4, No. 1 Jan.-Feb. 1982.
Hirschbein, et al; Magnetic separations in chemistry and biochemistry; Chemtech Mar. 1982.
Ollerich; Enzyme-Immunoassay: A Review J. Clin Chem Clin Biochem vol. 22, 1984 pp. 895-904.
Guesdon, et al.; Magnetic enzyme immunoassay for measuring human IgE; J. Allergy Clin Immunol Jan. 78; vol. 61, No. 1, 23-27.
Kamel, et al; Magnetizable Solid-Phase Fluoroimmunoassay of Phenytoin in Disposable Test Tubes; Clin chem 26/9/1281-1284 (1980).
Klibanov; Immobilized Enzymes and Cells as Practical Catalysts; Science vol. 219.
Mosbach, et al; Magnetic ferrofluids for preparation of magnetic polymers and their application in affinity chromatography; Nature vol. 270 Nov. 17, 1977.
Dawes, et al.; Radioimmunoassay of Digoxin Employing Charcoal Entrapped in Magnetic Polyacrylamide Particles; Clinica Chimica Acta 86 1978; 353-356.
Nye,et al., Solide Phase, Magnetic Particle Radioimmunoassay; Clinica Chimica Acta 69(1976) 387-396.
Hersh,et al; Magnetic Solid Phase Radioimmunoassay; Clinica chimica Acta, 63 1975 69-72.
Pourfarzaneh, et al., Cortisol Directly Determined in Serum by Fluoroimmunoassay with Magnetizable Solid Phase; Clin Chem 26/6 730-733.
Kamel, et al., Nove 125I-Labeled Nortriptyline Derivatives and Their Use in Liquid Pahse or Magnetizable Solid Pahse Second-Antibody Radioimmunoassays; Clin Chem 25/12, 1997-2002 (1979).
Ithakissioset al., Use of Protein Containing Magnetic Microparticles in Radioassays; Clin chem 23/11; 2072-1079 (1977).
Robinson; The Properties of Magnetic Supports in Relation to Immobilized Enzyme Reactors; Biotech and Bioeng. vol. XV 1973.
Carter; Preparation of Ligand Free Human Serum for Radioimmunoassay by Adsorption on Activated Charcoal; Clin Chem 24/2, 362-364(1978).
Jacobs; Separation Methods in Immunoassays; The Ligand Quarterly vol. 4, No. 4, 1981.
Rembaum et al., Synthesis and Reactionsof Hydrophilic Functional Microspheres; J. Macromaol Sci Chem A13(5) 603-632 (1979).
Pourfarzaneh, et al, Production and Use of Magnetizable Particles in Immunoassay, The Ligand Quarterly, vol. 5, No. 1, 1982.
Kaiser, et al., Magnetic Properties of Stable Dispersions of subdomain Magnetite Particles; Journal of Applied Physics; vol. 41, No. 3, Mar. 1970.
Halling et al., Magnetic supports for immobilized enzymes and bioaffinity adsorbents; Enzyme Microb Technol. 1980 vol. 2, Jan.
Allman, et al., Fluoroimmunoassay of Progesterone in Human Serum or Plasma; Clin Chem 27/7 1176-1179-(1981).
Radioimmunoassay and Related Procedures in Medicine 1982.
Klingler, et al., Immunoassay of unconjugated estriol in serum of pregnant women monitored by chemiluminescence; Steroids, vol. 42, No. 2, Aug. 1983.
Wisdom; Enxyme Immunoassay; Clin Chem 22/8/1243-1255 (1976).
Scholmerich, et al., Bioluminescence and Chemiluminescence; New Perspectives.
Thorpe et al., �29!Enhanced Chemiluminescent Reactions Catalyzed by Horseradish Peroxidase; Method in Enzymology vol. 133.
Margel et al., Polyglutaraldehyde: A new reagent for coupling proteins to microspheres and for labeling cell surface receptors . . . ; Jounal of Immunologica Methods 28(1979) 341-353.
Margel; Polyaldehyde Microspheres as Probes for Cell Membranes; Ind. Eng. Chem. Prod. Res. Dev. 1982, 21, 343-348.
Sovetskaia Meditsina No Translation.
Margel, et al., Polyacrolein Microspheres as a New Tool in Cell Biology, J. Cell Sci. 56, 157-175 (1982).
Margel, et al., Cell Fractionation with Affinity Ligands Conjugated to Agarose-Polyacrolein Microsphere Beads; J. Cell Sci. 62, 149-159(1983).
Kreuter; Evaluation of Nanoparticles as Drug-Delivery Sysntems I: Preparation Methods. Pharm Acta Helv. 58 No. 7, 1983.
Margel, et al., Chelation of Mercury by Polymercaptal Microspheres: new Potential Antidote for Mercury Poisoning; Joun of Pharm. Sciences; vol. 71. No. 9, Sep. 1982.
Basch, et al., Cell Separation Using Positive Immunoselective Techniques, Journ. of Immunol. Methods, 56(1983) 269-280.
Kaplan,et al., The Selective Detection of Cell Surface Determinants by means of Antibodies and Acetylated Avidin Attached tooHighly Fluorescent Polymer Microspheres; Biochem and Biophysic Acta 728(1983)112-120.
Margel, et al., Novel Effective Immunoadsorbents Based on Agarose-Polyaldehyde Microsphere Beads: Synthesis and Affinity Chromatography, Analytical Biochem. 128 342-350(1983).
Marcus, et al., A New Immunoadsorbent for Hemoperfusion: Agarose-Polyacrolein Microsheres Beads; Biomat Med. Dev., Art. Org. 10(3) 157-171 (1982).
Merivuori, et al., Cell Labelling and separation with polyglutaraldehyde microspheres; Exp Cell Res 130 (1980).
Kempner,et al., Electrophoretic cell sepatation using polyacrolein microspheres, Electrophosesis 1982, 3, 109-113.
Kumakura et al.,; Polymeric Microspheres for Immunoresearch; Immunological communications 13(2), 119-125(1984).
Morimoto et al., Dispersion State of Protein stabilized Magnetic Emulsions; Chem Pharm Bull 30(8) 3024-3027(1982).
Boland et al., The Ciba Corning ACS:180 Benchtop Immunoassay Analyzer; Clin Chem 36/9, 1598-1602 (1990).
ACS:180 Automated Chemiluninescence System.
Rembaum et al., Immunomicrospheres: Reagents for Cell Labeling and Separation, Science vol. 208. 25 Apr. 1980.
Tokes et al., Synthesis of adriamycin coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity; Proc Natl. Acad Sci. USA vol. 79; 2026-2030 Mar. 1982.
Margel et al., Synthesis and Characterization of Poly(glutaraldehyde). A Potential Reagent for Protein Immobilization and Cell Separation; Macromolucule vol. 13, No. 1, Jan. Feb. 1980.
Margel; Characterization and Chemistry of Polyaldehyde Microshpheres; Journ of Polymer Science vol. 22, 3521-3522(1984).
Marcus et al., Extracorporeal removal of specific antibodies by hemoperfusion through the immunosorbent agarase-polyacrolein micrsphere beads: Remaoval of Anti-bovine serum albumin in animals; Journ of Viomed Materials Research vol. 18 1153-1167(1984).
Margel; Agarose polyacrolein microsphere beads;Febs Letter; vol. 145 No 2; Aug. 1982.
Hage et al., High performance immunoaffinity chromatography and Chemilumisncent Detection in the Automation of a Parathyroid Hormone Sandwich Immunoassay; Anal. Chem 1991, 63, 586-595.
Bronstein et al., Instrumentation for luminescent assays; ACL: 33.
Campbell, Chemiluminescence Principles and Applications in Biology and Medicine.
The Ideal chemiluminometer. Sec. 2.4.
Chemiluminescence Immunoassay Sec. 8.2.
O'Brien et al., The magic lite system and acridinium esterbased immunoassays; Immunoassay Automation: A practical guide.
Dudley; Chemiluminescence Immunoassay: An Altermantive to RIA; Laboratory Medicine vol. 21, No. 4, Apr. 1990.
Dyke; Luminescence Immunoassay and Molecular Applications.
Luminescence Immunopassay and Molecular Applications; pp. 69-75.
Luminescence Immunopassay and Molecular applications; pp. 149-156.
Woodhead et al., Magic Lite Design and Development, Journ of Bioluminescence vol. 4, 611-614 (1989).
Express. New Intellegent random access cheimistry analysis Circle No. 578.
Shamberger et al., Evaluation of bichromatic random access analyzer; Analyzer Oct. 1989, 22.
The Lancet jan. 14, 1984, vol. 1 1984.
550 EXPRESS Shemistry Analyzer.
T3 Uptake �1251! Radioassay Magic Ciba Corning.
Quality Value. Customer Satisfaction Ciba Corning Diagnostics Corp.
Corning Magic Lite II.
ACS-180.
Berry et al., A Laboratory and Clinical Evaluation of an Immunochemiluminometric Assay of Thyrotropin in Serum; Clin Chem. vol. 34. No. 10, 1988.
Weeks et al., Chemiluminescence immunoassay: an overview; Clin Science 1986 70,403-408.
Weeks et al., Acridinium Esters as High-Specific-Activity Labels in Immunoassay; Clin Chem 29/8, 1474-1479(1983).
Shridi et al., A direct fluoroimmunoassay for conjugated chenodeoxycholic acid using antibody coupling to magnetisable particles; Ann Clin Biochem 1980; 17:188-191.
Sidki et al., Direct determination of primidone in serum of plasma by a magnetisable solid-phase fluoroimmunoassay; Ann Clin Biochem 1983:20:227-232.
Abdulla et al., Development of a Magnetisable solid-phase fluoroimmunoassay for primaquine and carboxyprimaquine; Southeast Asian J. Trop Med. Pub Hlth. vol. 20, No. 3, 1989.
Ciba Corning Laboratory Diagnostic Reagents and Systems packet.
Patent Abstracts of Japan vol. 16 No. 225(p. 1360).
Symbol: A New Communications Medium fo the information Age.
European Search Report ep 92 30 1483.
The Future of Bar Coding.
Symbol Technologies: The Bar Code Data Capture Company.
Symbol Just What the Doctors Ordered: Met Path Boosts Qualigy, Beats the Competition with PDF41.
Symbol: A PDF417 Primer: A guide to understanding second generation bar codes and portable data files.

Method of performing a process for determining an item of interest in a sample

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

US Referenced Citations (784)

Foreign Referenced Citations (176)

Non-Patent Literature Citations (84)